201
|
Yu Y, Ye X, Yang J, Chen L, Zhang M, He Y, Chen Z. Application of a shear-wave elastography prediction model to distinguish between benign and malignant breast lesions and the adjustment of ultrasound Breast Imaging Reporting and Data System classifications. Clin Radiol 2021; 77:e147-e153. [PMID: 34836632 DOI: 10.1016/j.crad.2021.10.016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2021] [Accepted: 10/19/2021] [Indexed: 12/21/2022]
Abstract
AIM To explore a real-time shear-wave elastography (SWE) prediction model distinguishing benign from malignant breast lesions and to determine its application in adjusting ultrasound Breast Imaging Reporting and Data System (BI-RADS) classifications. MATERIALS AND METHODS Four hundred and sixty-eight patients with 488 breast lesions were enrolled. Patients underwent hollow-needle puncture or surgical resection for histopathological examinations. Ultrasound examinations, both conventional ultrasound and real-time SWE, were performed <2 weeks prior to sampling. Statistical analyses were implemented to distinguish benign from malignant breast lesions and adjust ultrasound BI-RADS 3 and 4a classifications. RESULTS The real-time SWE indicators Emax and Ecol showed the highest diagnostic efficiency in distinguishing between benign and malignant lesions through quantitative and qualitative indicators, respectively. The area under the curve (AUC) for Emax was 0.837 while that for Ecol was 0.828. The AUC of the real-time SWE prediction model, constructed by multivariate logistic regression, for diagnosing benign and malignant breast lesions was 0.850. CONCLUSION The real-time SWE prediction model aids in the differential diagnosis of benign and malignant breast lesions but cannot replace conventional ultrasound. The model improves the diagnostic performance of ultrasound BI-RADS 3 and 4a classifications.
Collapse
|
202
|
Song ZW, Zhang M, Zhang X, Zhao ZP, Huang ZJ, Li C, Deng XQ, Wang LM. [Study on community health management and control of hypertension in patients aged 35 years and above in China, 2015]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2021; 42:2001-2009. [PMID: 34818847 DOI: 10.3760/cma.j.cn112338-20210727-00590] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Objective: To understand the current status of community health management, treatment and control of hypertension in patients aged 35 years and above in China in 2015, and identify the influencing factors. Methods: Using the questionnaire survey results and physical measurement information collected by China Chronic Diseases and Nutrition Monitoring System in 2015, hypertension patients aged 35 years and above diagnosed at township health center level (community health service centers) or above were selected as the research subjects. The patients were complexly weighted to analyze their general characteristics, community health management, treatment and control status. Results: This study included 23 974 hypertension patients aged 35 years and above diagnosed by medical and health institutions at township level and above in 2015. After complex weighting, the community health management rate of hypertension patients aged 35 years and above was 54.10% (95%CI: 51.02%-57.17%), the standardized community management rate was 45.72% (95%CI: 42.93%-48.51%), the treatment rate was 88.16% (95%CI: 87.00%-89.31%), and the control rate was 22.67% (95%CI: 21.25%-24.09%), the treatment control rate was 27.76% (95%CI: 26.09%-29.42%). Multivariate analysis showed that patients in urban areas as well as in rural areas who were aged over 65 years old (OR=1.40, 95%CI: 1.05-1.87; OR=3.11, 95%CI: 2.22-4.36), taking medicine as prescribed (OR=2.15, 95%CI: 1.46-3.15; OR=1.35, 95%CI: 1.13-1.62), monitoring blood pressure (OR=2.34, 95%CI: 1.88-2.90; OR=3.10, 95%CI: 2.72-3.53) were more willing to accept community health management of hypertension. Urban hypertension patients with high education level (OR=0.51, 95%CI: 0.39-0.66), moderate alcohol consumption (OR=0.69, 95%CI: 0.57-0.84) or excessive alcohol consumption (OR=0.73, 95%CI: 0.58-0.92) had a poor acceptance of community hypertension management. Overweight (OR=0.74, 95%CI: 0.61-0.91; OR=0.83, 95%CI: 0.71-0.98), obesity (OR=0.54, 95%CI: 0.45-0.65; OR=0.67, 95%CI: 0.54-0.83) patients in urban areas as well as in rural areas with hypertension had poor blood pressure control, and patient taking medication as prescribed (OR=4.58, 95%CI: 3.16-6.63; OR=2.84, 95%CI: 2.18-3.69) had better blood pressure control. Urban hypertension patients in central China (OR=0.74, 95%CI: 0.61-0.89) or with excessive alcohol consumption (OR=0.72, 95%CI: 0.54-0.97) had poor blood pressure control while urban hypertension patients with other chronic diseases (OR=1.22, 95%CI: 1.04-1.44) and participating in standardized hypertension community management (OR=1.29, 95%CI: 1.06-1.58) had better blood pressure control.Rural hypertension patients who located in central and western China (OR=0.71, 95%CI: 0.58-0.87; OR=0.62, 95%CI: 0.47-0.80), with moderate alcohol consumption (OR=0.81, 95%CI: 0.67-0.98), taking salt more than 6 g per day (OR=0.80, 95%CI: 0.69-0.93) had poor blood pressure control, and the rural hypertension patients who underwent blood pressure monitoring (OR=1.38, 95%CI: 1.18-1.61) had better blood pressure control. Conclusions: The community health management of hypertension in patients aged 35 years and above has been improved in China, but there is still a certain gap between the control of hypertension and related indicators. It is necessary to take multi standardized intervention measures for the better prevention and control of hypertension.
Collapse
|
203
|
Zhang M, Li JL, Wang RF, Guan WB, Wang LF. [Clinicopathological analysis of abdominal epithelioid inflammatory myofibroblastic sarcoma in children]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2021; 50:1272-1274. [PMID: 34719169 DOI: 10.3760/cma.j.cn112151-20210219-00149] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
204
|
Zhang M, Duan HL, Wang LM, Gao W, Yao YY, Teng LH. [Clinicopathological features and molecular characteristics of tall cell and hobnail variants of papillary thyroid carcinoma]. ZHONGHUA BING LI XUE ZA ZHI = CHINESE JOURNAL OF PATHOLOGY 2021; 50:1234-1239. [PMID: 34719160 DOI: 10.3760/cma.j.cn112151-20210630-00473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the clinicopathological and molecular genetic characteristics of tall cell variant and hobnail variant of papillary thyroid carcinoma (PTC). Methods: Twenty-one cases of tall cell variant (TCV-PTC) of PTC (TCV-PTC) and ten cases of hobnail variant of PTC (HV-PTC), as the highly aggressive group, were collected from Xuanwu Hospital from August 2009 to August 2015. Twenty-two cases of follicular variant and 21 classical PTC cases were included as control. Relevant clinical and pathologic data were obtained, and in some cases, paraffin samples were selected for gene mutation spectrum analysis using second generation sequencing. Results: There were 18 males and 56 females; 57 patients were younger than 55 years of age, and 17 patients were 55 years or older. The mean tumor size was 1.6 cm for the high-aggressive group (TCV-PTC and HV-PTC), 1.1 cm for the follicular subtype, and 1.6 cm for the classical type. There were 54 cases with thyroid capsule invasion, 24 cases with extra-thyroidal invasion, and 45 patients with lymph node metastases. Regional recurrence occurred in 7 cases, no recurrence in 54 cases, and 13 patients were lost to follow-up. The highly aggressive group was more likely to show extra-thyroidal invasion, lymph node metastases and recurrence than those with classical PTC (P<0.05). Within this cohort, BRAF V600E mutation was detected in 53 cases and TERT promoter mutation in 6 cases. Compared with the single mutation group and no mutation group, BRAF and TERT promoter co-mutation group was more commonly detected in older age, male, larger tumor size and more prone to extra-thyroid invasion (P<0.05). In addition, among BRAF and TERT co-mutation cases, the highly-aggressive group accounted for the highest proportion (5/6). Conclusions: TCV-PTC and HV-PTC, as highly-aggressive variants of PTC, show more aggressive biologic behavior (more lymph node metastasis, external thyroid invasion and recurrences) than the classical and follicular variants of PTC. Coexisting BRAF and TERT promoter mutations may be associated with invasive biologic behavior.
Collapse
|
205
|
Zhang Q, Ma Y, Zhang M, Wang Y, Wu W. Diagnostic accuracy of interleukin-27 in tuberculous pleurisy: a systematic review and meta-analysis. QJM 2021; 114:568-576. [PMID: 32652017 DOI: 10.1093/qjmed/hcaa215] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Revised: 06/03/2020] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE This study aimed to conduct a systematic review of the diagnostic value of interleukin-27 (IL-27) for tuberculous pleurisy (TP). METHODS Literature on IL-27 diagnosis of TP was retrieved and screened from six databases (four English databases and two Chinese databases). The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio and summary receiver operating characteristic curve (SROC) were measured to assess accurately the comprehensive evaluation of IL-27 for TP. RESULTS Eleven studies with a total of 1454 patients were identified in the analysis. The combined diagnostic value of IL-27 for TP was as follows: sensitivity of 0.95 (95% confidence interval [CI]: 0.93-0.97), specificity of 0.91 (95% CI: 0.89-0.92), positive likelihood ratio of 13.99 (95% CI: 7.01-27.93), negative likelihood ratio of 0.07 (95% CI: 0.05-0.10), diagnostic odds ratio of 275.20 (95% CI: 112.83-671.23) and area under the SROC of 0.9830. CONCLUSION IL-27 has an excellent diagnostic value for TP and could be used as a diagnostic biomarker for TP.
Collapse
|
206
|
Zhang M, Liu X, Wen F, Wu Q, Zhou K, Bai L, Li Q. First-line Cemiplimab versus Standard Chemotherapy in Advanced Non-small Cell Lung Cancer Patients with at Least 50% Programmed Cell Death Receptor Ligand-1 Positivity: Analysis of Cost-effectiveness. Clin Oncol (R Coll Radiol) 2021; 34:e123-e129. [PMID: 34736841 DOI: 10.1016/j.clon.2021.10.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2021] [Revised: 09/13/2021] [Accepted: 10/18/2021] [Indexed: 02/08/2023]
Abstract
AIMS The EMPOWER-Lung 1 trial showed that cemiplimab significantly prolongs the duration of progression-free survival and overall survival in advanced non-small cell lung cancer (NSCLC) patients with at least 50% programmed cell death receptor ligand-1 (PD-L1) positivity, yet the financial burden may limit its use. The aim of the present study was to evaluate the cost-effectiveness of cemiplimab versus chemotherapy in a US setting. MATERIALS AND METHODS A Markov model, with three mutually exclusive health states, was used to compare the expected health outcomes and cost of cemiplimab with chemotherapy. Survival data and transition probabilities were collected from the EMPOWER-Lung 1 trial. Utility values and costs are publicly available from open sources. One-way and probabilistic sensitivity analyses were conducted in both the whole population and subgroups to test the robustness of the parameters and structure. RESULTS Treatment of NSCLC with cemiplimab yielded an extra 1.07 quality-adjusted life years (QALYs) at an additional cost of $98 211 compared with chemotherapy, associated with an incremental cost-effectiveness ratio of $91 891/QALY and an incremental net health benefit of 0.087 QALYs at a willingness to pay threshold of $100 000/QALY. The probabilistic sensitivity analysis indicated that cemiplimab provided an 83.2% probability of being cost-effective. One-way sensitivity analysis suggested that the price of cemiplimab was the chief driver in this model. A subgroup analysis showed that cemiplimab was the preferred incremental net health benefit in more than half of the subgroups, including patients with squamous type disease and metastases. CONCLUSIONS Cemiplimab is a cost-effective option in the first-line treatment of NSCLC in patients who are at least 50% PD-L1 positive from an American perspective.
Collapse
|
207
|
Acklin S, Zhang M, Gillenwater J, Du W, Patra M, Yu J, Xia F. SIRT2 Promotes Murine Melanoma Progression Through Natural Killer Cell Inhibition. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
208
|
Fu JH, Zhao N, Liu B, Fang XD, Chen T, Zhang M, Liu Z. [Advances in clinical application of obstruction catheter in prevention and treatment of intestinal obstruction]. ZHONGHUA WEI CHANG WAI KE ZA ZHI = CHINESE JOURNAL OF GASTROINTESTINAL SURGERY 2021; 24:931-935. [PMID: 34674470 DOI: 10.3760/cma.j.cn.441530-20200305-00120] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Intestinal obstruction is one of the most common diseases in abdominal surgery, and its prevention and treatment is a clinical difficulty. Although surgical operation can solve the symptoms of obstruction, there are many postoperative complications, and it is easy to develop re-obstruction due to postoperative abdominal adhesion. The internal fixation of small intestine with obstruction catheter provides a new idea for the prevention of postoperative adhesive bowel obstruction. The use of transanal ileus catheter provides the possibility of direct intestinal anastomosis after resection of malignant obstruction in the left hemicolon and can reduce the incidence of postoperative complications. However, sufficient attention should be paid to the related complications, and prevention and treatment should be planned. It is important to note that the use of obstruction catheter is only one of the conservative treatments for bowel obstruction, and it is not a complete replacement of surgery. Surgical treatment should still be considered, if the catheter fails to significantly move, if the obstructive symptoms do not significantly improve 5 days after catheterization.
Collapse
|
209
|
Liu JH, Zhang M, Chen XY, Zhang Y, Xu YX. Modification of Enteromorpha prolifera with dielectric barrier discharge plasma to enhance malachite green adsorption. Lett Appl Microbiol 2021; 74:103-108. [PMID: 34695247 DOI: 10.1111/lam.13592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 09/12/2021] [Accepted: 10/21/2021] [Indexed: 11/28/2022]
Abstract
Dyes, a kind of visible chemical, have severe deleterious effects on human health and ecological environment. In this work, batch biosorption experiments were carried out under various experimental conditions such as pH value and agitation time to optimize the potentiality of Enteromorpha prolifera for the removal of malachite green (MG) dye from aqueous solution (70·7%). Then, the algal biomass was treated with a dielectric barrier discharge (DBD) in helium for 4 and 10 min to enhance MG removal efficiency (84·7 and 96·6%). In addition, Fourier-transform infrared spectroscopy in combination with scanning electron microscopy was employed to monitor the chemical and physical changes of algal cells treated by DBD. This study illustrates that DBD may serve as an effective tool to activate the functional groups on the cell wall surface for dye binding, and it even offers an alternative new technique to improve the adsorption properties of native biosorbents for the removal of toxic dyes from wastewater.
Collapse
|
210
|
Zhang H, Zhang M. The association between methylation in specific cpg sites of slc6a4 gene promoter region and prognosis of acs patients with different level of burnout. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Given that psychosocial disorders like depression and burnout are top causes of disease burden, meanwhile have negative effect on the prognosis of acute coronary syndrome (ACS), many studies mounted on their pathogenesis. Recently, epigenetic modifications of stress-related genes like serotonin transporter gene (SLC6A4) have been found to be involved in these disease courses, but the study to investigate the influence of methylation of SLC6A4 gene on the association of these disorders and prognosis of ACS is not found.
Objectives
To investigate the association of methylation of SLC6A4 gene and prognosis of patients with ACS who were in different level of burnout.
Methods
Patients with first onset of ACS were enrolled, and their blood sample, demographic and clinical data were collected. Then they were evaluated baseline level of burnout, anxiety, depression, quality of life and heart rate variability (HRV) before discharge, by Copenhagen Burnout Inventory (CBI), Hospital Anxiety and Depression Scale (HADS), 8-item Short Form Generic Health-Related Quality-of-life Questionnaire (SF-8), Seattle Angina Questionnaire (SAQ) and ambulatory electrocardiogram (24h-AECG) respectively. At one-month and six-month's follow-up, their physical performance was evaluated by Short Physical Performance Battery (SPPB) and same indices above were assessed repeatedly. Genomic DNA was extracted from whole blood, and methylation level in 11 CpG sites of SLC6A4 gene promotor region were tested by bisulfite sequencing PCR (BSP) technique. Last, the associations among burnout, anxiety, depression, and their interactions with methylation were analyzed by IBM SPSS Statistics 24.0, so as the association of methylation and the prognosis of ACS.
Results
74 patients were enrolled. Chi-square test implied that methylation of CpG7 was more obvious in non-anxiety group compared to anxiety group. And log linear model was used to explore the association among burnout, anxiety, depression, and their interactions with methylation, only the interaction of non-methylation of CpG7 and anxiety was positively correlated to the distribution of frequency. Next, five CpG sites (CpG6–10) were included in generalized estimating equations (GEEs) to analyze the association of methylation and prognosis indices of ACS patients. Results showed that methylation of CpG7 was positively correlated to standard diviation of NN intervals (SDNN), square root of the mean squared differences of successive NN intervals (RMSSD), high frequency (HF), low frequency (LF), very low frequency (VLF), total power (TP), and no significant relations were found among the score of SPPB, SF-8, SAQ and methylation.
Conclusions
Methylation in CpG7 of SLC6A4 gene promotor region may foretell a good prognosis of ACS patients by being correlated to less anxiety. Epigenetic modifications could be promising biomarkers to help identifying people that need special rehabilitation strategy.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Nature Science Foundation of Yunnan Province; Yunnan Health Training Project of High Level Talents
Collapse
|
211
|
Lui G, Wong CK, Chan M, Chong KC, Wong R, Chu I, Zhang M, Li T, Hui D, Lee N, Chan P. Host inflammatory response is the major marker of severe respiratory syncytial virus infection in older adults. J Infect 2021; 83:686-692. [PMID: 34614399 DOI: 10.1016/j.jinf.2021.09.024] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Revised: 09/09/2021] [Accepted: 09/13/2021] [Indexed: 12/26/2022]
Abstract
OBJECTIVES We aim to study the viral kinetics and host inflammatory response of RSV infection in older adults, and their correlation with disease severity. METHODS We performed a prospective observational study in adults with RSV infection. We serially collected nasal-throat swabs for quantification of RSV-A and RSV-B viral load, and peripheral blood samples for measurement of cytokine/chemokine concentrations. The study endpoints were (i) requiring supplemental oxygen therapy, and (ii) non-invasive ventilation, intensive care, or died within 30 days of admission. We performed multivariable logistic regression models to identify independent variables for severe disease. RESULTS We enrolled 71 hospitalized patients and 10 outpatients treated for RSV infection (median age 75 years, 51% male, and 74% with comorbidities). Among hospitalized patients, 61% required supplemental oxygen therapy, and 18% had severe disease requiring non-invasive ventilation or intensive care, or died within 30 days. Inflammatory cytokine/chemokines IL-6, CXCL8/IL-8, CXCL9/MIG and CXCL10/IP-10 increased significantly during the acute phase of illness. IL-6 concentration was independently associated with severe disease after adjusting for confounding factors. RSV viral load was not associated with disease severity throughout the course of illness. CONCLUSION Host inflammatory response is a major marker of severe disease in older adults with RSV infection.
Collapse
|
212
|
Wang H, Xing R, Li M, Zhang M, Zhang G, Zhang X, Ma Z. P48.08 The Efficacy and Clinical Survival Outcome of Different First-Line Treatments in EGFR Mutant Non-Small Cell Lung Cancer With Brain Metastases. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.519] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
213
|
He Y, Zhang M, Song J, Warman ML. Cell depleted areas do not repopulate after diphtheria toxin-induced killing of mandibular cartilage chondrocytes. Osteoarthritis Cartilage 2021; 29:1474-1484. [PMID: 34166809 DOI: 10.1016/j.joca.2021.06.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/14/2020] [Revised: 06/04/2021] [Accepted: 06/13/2021] [Indexed: 02/02/2023]
Abstract
OBJECTIVE Growth of mandibular condylar cartilage (MCC) is associated with cell proliferation within the polymorphic cell layer and subsequent differentiation into chondrocytes that reside along the condylar surface and along the cartilage/subchondral bone interface. We examined whether cells in the polymorphic layer would proliferate and repopulate toxin-induced cell-depleted areas in MCCs of adult mice. METHOD We induced diphtheria toxin (DTA) expression (ROSA26l-s-lDTA) to cell-autonomously kill large fractions of MCC chondrocytes throughout the cartilage or along the articular cartilage surface with Aggrecan-CreERt2 (AcanCreERt2) or Lubricin-CreERt2 (Prg4CreERt2) Cre-recombinase-inducible mice, respectively. We examined MCCs from these mice shortly after cell killing or several months later with histology and confocal microscopy for evidence of chondrocyte proliferation and repopulation. RESULTS AcanCreERt2-induced DTA expression killed an average of 53% MCC chondrocytes in adult mice after 1 week (39-66%, 95% confidence interval (CI)). Twelve weeks later, surviving chondrocytes had proliferated but not migrated to cell depleted areas. Prg4CreERt2-induced DTA expression killed an average of 24% surface chondrocytes in mice after 5 weeks (14-34% CI). After thirteen weeks there was 34% fewer surface chondrocytes (4-63% CI) in Prg4CreERt2 DTA-induced mice compared to controls. CONCLUSION In adult mice, after diphtheria toxin-mediated chondrocyte killing, cell depleted areas within MCC cartilage are not repopulated by new cells.
Collapse
|
214
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, Abramowicz H, Abreu H, Abulaiti Y, Abusleme Hoffman AC, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Agarwala J, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Arcangeletti C, Arce ATH, Arena E, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asbah NA, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Auricchio S, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Badea A, Bagnaia P, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Ballabene E, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Barak L, Barberio EL, Barberis D, Barbero M, Barbour G, Barends KN, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnett BM, Barnett RM, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bashta I, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HP, Becker K, Becot C, Beddall AJ, Bednyakov VA, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beirao Da Cruz E Silva C, Beirer JF, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Bethke S, Betti A, Bevan AJ, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Bielski R, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Bird GA, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao Y, Capua M, Carbone A, Cardarelli R, Cardillo F, Carducci G, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carnesale M, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casadei D, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavalli N, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chala M, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Chekanov S, Chekulaev SV, Chelkov GA, Chen A, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng CL, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clavijo Columbie JM, Clawson SE, Clement C, Clissa L, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Barrue RF, Coelho Lopes De Sa R, Coelli S, Cohen H, Coimbra AEC, Cole B, Collot J, Conde Muiño P, Connell SH, Connelly IA, Conroy EI, Conventi F, Cooke HG, Cooper-Sarkar AM, Cormier F, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cote BM, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, De Sousa MJDCS, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Darmora S, Dattagupta A, D'Auria S, David C, Davidek T, Davis DR, Davis-Purcell B, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Degens J, Deiana AM, Del Peso J, Delabat Diaz Y, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delsart PA, Demers S, Demichev M, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Diaconu C, Dias FA, Vale TDD, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dinu IM, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Yildiz HD, Düren M, Durglishvili A, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eckerova B, Eggleston MG, Egidio Purcino De Souza E, Ehrke LF, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Ghazali Y, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans G, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fadeyev V, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fan Y, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Freegard AC, Freeman PM, Freund B, Freund WS, Freundlich EM, Froidevaux D, Frost JA, Fu Y, Fujimoto M, Fullana Torregrosa E, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Sciveres M, Gardner RW, Garg D, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Gledhill GR, Glisic M, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gombas JP, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, González Andana RY, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goumarre V, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Graham K, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray HM, Grefe C, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo L, Guo Y, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Habedank M, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Halser L, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hara K, Harenberg T, Harkusha S, Harris YT, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, He Y, Heath MP, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hodkinson BH, Hoecker A, Hofer J, Hohn D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Honan BP, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Ingebretsen Carlson T, Introzzi G, Iodice M, Ippolito V, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jagfeld CS, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jézéquel S, Jia J, Jia Z, Jiang Y, Jiggins S, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones TJ, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Ke Y, Keaveney JM, Keeler R, Keller JS, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kilgallon A, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein L, Klein MH, Klein M, Klein U, Klimek P, Klimentov A, Klimpel F, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knight TM, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korn S, Korolkov I, Korolkova EV, Korotkova N, Kortman B, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Kremer JA, Kretzschmar J, Kreul K, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kumar M, Kumari N, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, Lacasta C, Lacava F, Lacker H, Lacour D, Lad NN, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lalloue N, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Leban B, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Leeuw LL, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li C, Li CQ, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu G, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magro J, Mahon DJ, Maidantchik C, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manisha M, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Mathisen T, Matic A, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Meloni F, Melzer A, Gouveia EDM, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Mentink M, Meoni E, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Miralles Lopez M, Mironova M, Mitani T, Mitsou VA, Mittal M, Miu O, Miyagawa PS, Miyazaki Y, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohammed AF, Mohapatra S, Mokgatitswane G, Mondal B, Mondal S, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Morange N, Moreira De Carvalho AL, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Muenstermann D, Mullier GA, Mullin JJ, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin M, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nanjo H, Napolitano F, Narayan R, Naryshkin I, Naseri M, Nass C, Naumann T, Navarro G, Navarro-Gonzalez J, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson K, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neundorf J, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Norfolk MB, Norisam RRB, Novak J, Novak T, Novgorodova O, Novotny L, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Seabra LFO, Olivares Pino SA, Oliveira Damazio D, Oliveira Goncalves D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Ozturk S, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Panchal DK, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Penzin M, Peralva BS, Perego MM, Peixoto APP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perganti M, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petroff P, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pezzullo G, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Piazza F, Picazio A, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pizzi DA, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Pollock ZB, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Postolache P, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Principe Martin MA, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Rabanal Bolanos G, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ran K, Rassloff DF, Rauch DM, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezaei Estabragh M, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Riedler P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Rinnagel MP, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Roberts BA, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rousso D, Rovelli G, Roy A, Rozanov A, Rozen Y, Ruan X, Ruby AJ, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sanchez Sebastian V, Sandaker H, Sander CO, Sanderswood IG, Sandesara JA, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauer C, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schlag B, Schleicher KE, Schlenker S, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schovancova J, Schramm S, Schroeder F, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Scutti F, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Selem LP, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shaheen R, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Sharma S, Shatalov PB, Shaw K, Shaw SM, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simsek S, Sinervo P, Sinetckii V, Singh S, Sinha S, Sinha S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder S, Sobie R, Soffer A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Solomon S, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, Soumaimi Z, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Standke M, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Starko DM, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Strom LR, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su S, Su W, Su X, Suarez NB, Sugizaki K, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun S, Sun X, Gudnadottir OS, Suster CJE, Sutton MR, Svatos M, Swiatlowski M, Swirski T, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka A, Tanaka J, Tanaka R, Tao Z, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tayalati Y, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Themistokleous N, Theveneaux-Pelzer T, Thielmann O, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tian Y, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Tlou SH, Tnourji A, Todome K, Todorova-Nova S, Todt S, Togawa M, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsiamis A, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsur O, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzanis P, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Uno K, Urban J, Urquijo P, Usai G, Ushioda R, Usman M, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vannoli L, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vaslin L, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veliscek I, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Verducci M, Vergis C, Verissimo De Araujo M, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vesterbacka ML, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vladimirov V, Voevodina E, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner C, Wagner P, Wagner W, Wahdan S, Wahlberg H, Wakasa R, Wakida M, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang P, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang WX, Wang X, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Wei C, Wei Y, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilbern DJ, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu J, Wu SL, Wu X, Wu Y, Wu Z, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yamaguchi N, Yamaguchi Y, Yamatani M, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zormpa O, Zou W, Zwalinski L. Search for New Phenomena in Final States with Two Leptons and One or No b-Tagged Jets at sqrt[s]=13 TeV Using the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 127:141801. [PMID: 34652194 DOI: 10.1103/physrevlett.127.141801] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Accepted: 07/30/2021] [Indexed: 06/13/2023]
Abstract
A search for new phenomena is presented in final states with two leptons and one or no b-tagged jets. The event selection requires the two leptons to have opposite charge, the same flavor (electrons or muons), and a large invariant mass. The analysis is based on the full run-2 proton-proton collision dataset recorded at a center-of-mass energy of sqrt[s]=13 TeV by the ATLAS experiment at the LHC, corresponding to an integrated luminosity of 139 fb^{-1}. No significant deviation from the expected background is observed in the data. Inspired by the B-meson decay anomalies, a four-fermion contact interaction between two quarks (b, s) and two leptons (ee or μμ) is used as a benchmark signal model, which is characterized by the energy scale and coupling, Λ and g_{*}, respectively. Contact interactions with Λ/g_{*} lower than 2.0 (2.4) TeV are excluded for electrons (muons) at the 95% confidence level, still far below the value that is favored by the B-meson decay anomalies. Model-independent limits are set as a function of the minimum dilepton invariant mass, which allow the results to be reinterpreted in various signal scenarios.
Collapse
|
215
|
Wang H, Wei C, Zhang G, Zhang M, Yan X, Zhang X, Niu Y, Yang J, Ma Z. P16.06 Comparison of Clinical Outcomes of Patients With Advanced NSCLC In Clinical Trials and in the Real World Received PD-1/PD-L1 Inhibitor. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
216
|
Wu K, Zhang M, Zhu L, Wang B, Xia B, Ma S, Chen X. P42.04 Prognosis Factors in Advanced Lung Cancer Patients Treated With Checkpoint Inhibitor-Based Immunotherapy. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
217
|
Song ZW, Zhang M, Wang ZH, Qi SG, Wang LM. [Summary of research methods of stroke disease burden in big data era]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2021; 42:1695-1699. [PMID: 34814603 DOI: 10.3760/cma.j.cn112338-20200707-00930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Stroke has high disability rate and high mortality rate, resulting in huge disease burden to society and individuals. In the context of highly informationization of global health system, countries have built and improved various public health information platform to provide support for health decision-making through public health information collection, classification, extraction, analysis and sharing in the research of disease burden of stroke. Based on the retrieval of domestic and foreign literatures, this paper summarizes the research methods of stroke-caused disease burden and its public health information sources in China, evaluates the significance of public health as well as the limitations of each research method of disease burden and describes the application and development of stroke-caused disease burden big data platform in the world, and provide suggestions for establishing a more modern and information-based stroke-caused disease burden evaluation system in China by analyzing the limitations of the existing stroke-caused disease burden evaluation system.
Collapse
|
218
|
Guan YQ, Zhang M, Zhang X, Zhao ZP, Huang ZJ, Li C, Wang LM. [Association between alcohol consumption and insomnia in employed floating population in China]. ZHONGHUA YU FANG YI XUE ZA ZHI [CHINESE JOURNAL OF PREVENTIVE MEDICINE] 2021; 55:1114-1122. [PMID: 34619930 DOI: 10.3760/cma.j.cn112150-20210610-00564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the relationship between alcohol consumption and insomnia among 18-59 years old employed floating population in mainland China, and provide scientific basis for the relevant policies to improve the sleep status of employed floating population from the perspective of alcohol consumption. Methods: Data were from Chinese Floating Population Chronic Disease Surveillance (2012). Floating population were selected from industries in 170 counties and districts of 31 provinces/autonomous regions, and Xinjiang Construction Corps in mainland China by using the stratified multistage cluster sampling. Demographic information, behavioral risk factors, insomnia, social pressure and chronic diseases were collected through using the face-to-face questionnaire. After complex weighting of the data, a multivariable logistic regression was used to explore the sleep status and its influencing factors among the employed floating population. Results: A total of 48 499 subjects were included in the analysis. The proportions of the employed floating population who never drank alcohol, drank small amount, and drank excessively were 48.3%, 41.8% and 9.9%, respectively. The prevalence of insomnia among the general, male and female employed floating population was 28.6%, 25.8% and 32.3%, respectively. The prevalence of insomnia among the employed floating population aged between 45 and 59 years old (32.2%) was higher than that in the population aged between 18 and 44 years old (28.2%). The multivariable logistic regression analysis showed that after adjusting confounding factors, compared with the employed floating population who never consumed alcohol as the reference group, the OR values of insomnia for the employed floating population with moderate drinking and excessive drinking were 1.40 and 1.53, respectively. The OR values of insomnia for the male and female employed floating population with moderate drinking were 1.28 and 1.53. The OR values of insomnia for the male and female employed floating population with excessive drinking were both 1.46. The OR values of insomnia for the population aged 18-44 years and 45-59 years with excessive drinking were 1.41 and 1.27. The OR values of insomnia for the population aged 18-44 years and 45-59 years with excessive drinking were 1.55 and 1.37. Conclusion: Small amount of drinking and excessive drinking are associated with insomnia among the employed floating population in mainland China. The association between excessive drinking and insomnia is stronger than that between small amount of drinking and insomnia.
Collapse
|
219
|
Qiu H, Dai Y, Huang T, Sun L, Zhuang L, Zhang M, Zou Y, Yuan X. 428P Retrospective cohort study of low-dose apatinib plus S-1 versus regorafenib and fruquintinib for refractory metastatic colorectal cancer. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.949] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
220
|
Qi C, Qin Y, Liu D, Gong J, Ge S, Zhang M, Peng Z, Zhou J, Zhang X, Peng X, Wang H, He C, Xiao J, Li Z, Shen L. 1372O CLDN 18.2-targeted CAR-T cell therapy in patients with cancers of the digestive system. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1481] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
221
|
Dai H, Zhang M, Zhang Q, Zhao S. 357P A phase II study of anlotinib in the treatment of recurrent high-grade glioma. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
222
|
Halloran B, Zhang M, Mbogori T, Friesen C. Postpartum Depression and Preconception Vitamin Supplementation: An Analysis of the Pregnancy Risk Assessment Monitoring System (PRAMS), 2016-2018. J Acad Nutr Diet 2021. [DOI: 10.1016/j.jand.2021.06.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
223
|
Liu X, Zhang M, Chen J. 1340P The characteristics of the intestinal flora of advanced non-small cell lung cancer in China and its role in chemotherapy based on metagenomics. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1941] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
224
|
Duan J, Zhang J, Yang H, Liu Q, Xie M, Zhang M, Chu Y, Zhou P, Yu S, Chen C, Wang M. Mineral deposition intervention through reduction of phosphorus intake suppresses osteoarthritic lesions in temporomandibular joint. Osteoarthritis Cartilage 2021; 29:1370-1381. [PMID: 34126199 DOI: 10.1016/j.joca.2021.05.061] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/28/2020] [Revised: 05/06/2021] [Accepted: 05/20/2021] [Indexed: 02/02/2023]
Abstract
OBJECTIVE To explore the suppressing impact of low phosphorus intake on osteoarthritic temporomandibular joint and the possible mechanisms of nuclear acid injury in the insulted chondrocytes. DESIGN Chondrocytes were loaded with fluid flow shear stress (FFSS) with or without low phosphorus medium. Seventy-two mice (sampled at 3-, 7- and 11-wk, n = 6) and forty-eight rats (sampled at 12-wks for different testing purpose, n = 6) were applied with unilateral anterior crossbite (UAC) with or without low phosphorus diet. In the FFSS model, the Ca and P content, molecules related to nucleic acid degradation and the mineral-producing responses in chondrocytes were detected. The effect of culture dish stiffness on chondrocytes osteogenic differentiation was measured. In the UAC model, the content of Ca and P in serum were tested. The condylar cartilage ossification and stiffness were detected using micro-CT, scanning electron microscope and atomic force microscope. RESULTS FFSS induced nucleic acid degradation, Pi accumulation and mineral-producing responses in the cultured chondrocytes, all were alleviated by low P medium. Stiffer dish bottoms promoted the osteogenic differentiation of the cultured chondrocytes. UAC stimulated cartilage degeneration and chondrocytes nucleic acid damage, increased PARP 1 and serum P content, and enhanced ossification and stiffening of the cartilage, all were suppressed by low phosphorus diet (all, P < 0.05). CONCLUSION Nucleic acid damage takes a role in phosphorus production in osteoarthritic cartilage, contributing to the enhanced mineralization and stiffness of the cartilage that in turn promotes cartilage degradation, which can be alleviated by low phosphorus intake.
Collapse
|
225
|
Zhang M, Zhao X, Liu Y, Yang J. Perceived stress and possible stressors in the general public in China during the COVID-19 pandemic. ETHICS, MEDICINE, AND PUBLIC HEALTH 2021; 18:100695. [PMID: 36569741 PMCID: PMC9765419 DOI: 10.1016/j.jemep.2021.100695] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Accepted: 06/02/2021] [Indexed: 12/27/2022]
Abstract
Background The COVID-19 pandemic is spreading worldwide and a study found that front-line medical staff reported high levels of perceived stress during this pandemic. However, some findings indicated that the general public had more psychological problems than front-line medical staff. Therefore, the current study aimed to investigate perceived stress levels and to identify possible stressors affecting the general public in China during the severe stage of COVID-19 pandemic. Methodology An anonymous questionnaire survey was conducted online from February 18 to25, 2020, with 1921 Chinese people aged 18-68 years (M = 29.28, SD = 10.66). Results Most participants reported low to mild perceived stress levels. Moreover, social stressors (e.g., disruption of normal life), rather than physical (e.g., burdened work) or psychological stressors (e.g., worried about self-infection) were the most frequently reported stressors of the general public. Conclusion In summary, our findings addressed an ongoing relevant situation affecting nations, communities, and individuals worldwide, and provided suggestions to regulate the perceived stress in the general public.
Collapse
|
226
|
Zhang M, Yang H, Zhu F, Xu R, Cheng Y. Transcript profiles analysis of citrus aquaporins in response to fruit water loss during storage. PLANT BIOLOGY (STUTTGART, GERMANY) 2021; 23:819-830. [PMID: 33797834 DOI: 10.1111/plb.13269] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Accepted: 03/22/2021] [Indexed: 05/02/2023]
Abstract
Water loss is an essential factor that affects the maintenance of quality of citrus fruit during postharvest handling and storage. Aquaporins (AQPs) play an important role in the transport of water across membranes. However, the expression profiling of AQPs is incomplete for citrus fruits during storage. In this study, a post-harvest storage experiment was performed using sweet orange fruits to determine changes in water loss and fruit quality. Also, genome-wide expression analysis of CsAQP genes was carried out in fruit of different citrus varieties during storage. Low humidity storage conditions accelerated the postharvest water loss and texture decline and increased the TSS content in the fruit. A total of 39 non-redundant CsAQP genes were identified. A comprehensive analysis of these genes demonstrated that all AQPs had conserved filter motifs in the different citrus varieties examined. Moreover, multiple expression analysis revealed AQPs had complex expression profiles upon water loss in citrus fruit, being time-specific in tight-skin varieties (orange and pomelo varieties), tissue-specific between peel and pulp, and variety-specific between loose-skin (mandarin varieties) and tight-skin varieties (such as sweet orange and pummelo). These results indicated that the relative humidity in storage environment affected the postharvest water loss and quality of citrus fruit. Besides, the alternation in AQPs expression may partially account for the different water loss ratio in citrus varieties and the transfer of water between the peel and the pulp of citrus fruit during storage.
Collapse
|
227
|
Han B, Wang S, Li G, Wang X, Chen Z, Zhao G, Chen Y, Li M, Li Y, Zhang M, Ai S. [Objective sleep characteristics and risk factors for sleep apnea in heart failure patients with different left ventricular ejection fraction]. NAN FANG YI KE DA XUE XUE BAO = JOURNAL OF SOUTHERN MEDICAL UNIVERSITY 2021; 41:1415-1419. [PMID: 34658358 DOI: 10.12122/j.issn.1673-4254.2021.09.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVE To investigate the objective sleep characteristics and the independent risk factors for sleep apnea in heart failure (HF) patients with different left ventricular ejection fractions (LVEF). METHODS A total of 107 patients with chronic HF hospitalized in the Department of Cardiology of our hospital from April, 2019 to October, 2020 were included in this study. According to the LVEF measured by echocardiography, the patients were divided into reduced ejection fraction (HFrEF) group (n=35), mid-range ejection fraction (HFmrEF) group (n=21), and preserved ejection fraction (HFpEF) group (n=51). The baseline demographic and clinical characteristics of the patients were recorded. To assess the objective sleep characteristics, whole night polysomnography was scheduled for all the patients. Spearman correlation and multinomial logistic regression analyses were used to explore the factors affecting objective sleep characteristics. RESULTS The patients in HFpEF group had significantly lower proportion of non-rapid eye movement sleep stage 1, apnea hypopnea index (AHI), and central sleep apnea (CSA) than those in HFrEF group (all P < 0.05). The baseline demographic data or sleep structures in HFmrEF group did not differ significantly from those in the other two groups. Spearman correlation analysis revealed significant correlations of the male sex, diuretics use, NT-proBNP, LVEF, and total cholesterol levels with the severity of AHI (all P < 0.05). After adjusting for potential confounders, multiple logistics regression analysis showed that age, drinking, and LVEF levels were independently associated with the severity of AHI (all P < 0.05). CONCLUSION Abnormal objective sleep architectures occur in all HF patients, manifested mainly by sleep apnea. The incidences of sleep apnea and CSA are lower in patients with HFpEF than in those with HFrEF. Age, drinking, and LVEF levels are independent risk factors for the occurrence and severity of sleep apnea.
Collapse
|
228
|
Zhang M, Li YG, Wang KY, Wang X, Dai LP, Wang P, Ye H, Shi JX, Yang XA, Zhang SX, Zhang JY. [Cost-effectiveness of anti-tumor associated antigen autoantibody screening for hepatocellular carcinoma in the population with chronic hepatitis B-related cirrhosis]. ZHONGHUA YI XUE ZA ZHI 2021; 101:2544-2551. [PMID: 34407581 DOI: 10.3760/cma.j.cn112137-20201229-03502] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To evaluate the cost-effectiveness of anti-tumor associated antigen autoantibody (TAAb) for hepatocellular carcinoma (HCC) screening in cirrhosis population with chronic hepatitis B (CHB). Methods: A simulated cohort of 40-year-old patients with CHB cirrhosis was established with a sample size of 10 000. Using TAAb screening alone or TAAb and AFP screening in parallel (TAAb + AFP) as the research strategy, and liver ultrasound and AFP screening in parallel (liver ultrasound + AFP) as the control strategy, the decision analysis Markov model was constructed and the model validity was evaluated. The 6-month cycle was simulated using TreeAge Pro 2020 software. Cost and quality-adjusted life years (QALY) were calculated. Incremental cost-effectiveness ratio (ICER) was used to compare the two strategies, and sensitivity analysis was used to evaluate the uncertainty of results. Results: The Markov model had a total of 11 outcomes, of which 7 were natural outcomes and 4 wereclinical intervention outcomes, and the goodness of fit was 0.969. The lifetime screening cost of TAAb+AFP strategy for HCC screening was 249 612 yuan/case, and the QALY per capita was 7.704 years. Compared with liver ultrasound +AFP strategy (247 805 yuan/case), the total health cost increased by 1 807 yuan/case, and the QALY obtained was 0.014. The ICER was 127 635 yuan /QALY. When the TAAb screening fee was higher than 889.552 yuan, or the discount rate was higher than 0.068, or the antiviral treatment compliance was lower than 45.1%, ICER > 212 676 yuan /QALY. When the single TAAb screening fee was 400-600 yuan, the TAAB+AFP strategy had cost effective value. When the willingness to pay was 70 892, 141 784 and 212 676 yuan /QALY, the probability of cost-effectiveness of TAAb+AFP strategy was 70.6%, 75.3% and 77.8%, respectively. Conclusion: It is cost-effective to use TAAb+AFP for early screening of liver cancer in Chinese population with CHB cirrhosis.
Collapse
|
229
|
Chen Q, Zhang M, Si F, Wang S, Xu X, Yu L, Lai K, Qiu Z. Flupentixol/melitracen for chronic refractory cough after treatment failure with other neuromodulators. Int J Tuberc Lung Dis 2021; 25:648-654. [PMID: 34330350 DOI: 10.5588/ijtld.21.0083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND: Gabapentin and baclofen are recommended for the treatment of chronic refractory cough (CRC). We investigated the efficacy of flupentixol/melitracen in patients unresponsive to these neuromodulators.METHODS: A total of 101 patients with CRC who failed to respond to gabapentin and baclofen were recruited, and treated with flupentixol/melitracen. The prevalence of cough resolution and changes in the Cough Symptom Score (CSS), cough thresholds to capsaicin, Hull Airway Reflux Questionnaire (HARQ), Leicester Cough Questionnaire (LCQ), Generalized Anxiety Disorder-7, Hamilton Anxiety Rating Scale, Patient Health Questionnaire-9, and Hamilton Depression Rating Scale-24 were evaluated after treatment.RESULTS: Ninety-eight patients (97.0%) completed the study. The overall successful cough resolution rate was 62.4% (63/101). Cough resolution was accompanied by an obvious decrease in the CSS and HARQ score and a remarkable increase in cough thresholds to capsaicin challenge and LCQ score, whereas anxiety and depression scores did not change significantly. The prevalence of adverse effects (e.g., insomnia and dizziness) was 21.8%. The prevalence of cough recurrence within 2 weeks after treatment cessation was 17.8%.CONCLUSION: Flupentixol/melitracen may be an efficacious option for CRC unresponsive to other neuromodulators.
Collapse
|
230
|
Bai J, Zhang M, Cao XS, Cao JJ. [The value of serum cystatin C for the evaluation of renal function damage in patients with proliferative diabetic retinopathy]. ZHONGHUA YI XUE ZA ZHI 2021; 101:2400-2404. [PMID: 34404134 DOI: 10.3760/cma.j.cn112137-20210522-01184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To investigate the value of serum cystatin C for the evaluation of renal function damage in patients with proliferative diabetic retinopathy (PDR). Methods: The clinical data of PDR patients treated in ophthalmic wards of Beijing Tongren Hospital from July 2019 to January 2021 were retrospectively analyzed. The estimated glomerular filtration rate (eGFR) was calculated by the abbreviated Modification of Diet in Renal Disease (MDRD) study equation. Based on the eGFR level, the patients were divided into no obvious renal function damage group [≥ 60 ml·min⁻¹·(1.73 m2)⁻1] and renal inadequacy group [<60 ml·min⁻¹·(1.73 m2)⁻1]. The clinical characteristics between the two groups were compared. Multivariate logistic regression analysis was performed to identify the relevant factors of renal inadequacy. The value of cystatin C to predict the renal inadequacy was calculated by the receiver operating characteristic (ROC) curves. Results: A total of 1 009 patients [593 males and 416 females; mean age: (52±12) years] were finally included in the study, with 192 cases (19.0%) and 817 cases (81.0%) in renal inadequacy group and no obvious renal function damage group, respectively. There were no significant statistically differences in gender, age, diastolic blood pressure, body mass index, fasting blood glucose and low-density lipoprotein between the two groups (all P>0.05). The systolic blood pressure, blood urea nitrogen, creatinine, uric acid, triglyceride, cholesterol and cystatin C were higher in the renal inadequacy group than those of no obvious renal function damage group (all P<0.05). However, the glycosylated hemoglobin, albumin and high-density lipoprotein were lower in the renal inadequacy group (all P<0.05). Multivariate logistic regression analysis showed that serum creatinine (OR=1.189, 95%CI: 1.101-1.284, P<0.001) and cystatin C (OR=3.175, 95%CI: 1.272-7.923, P=0.013) were independent risk factors for renal inadequacy in PDR patients. The ROC curve showed that cystatin C had a predictive value for renal inadequacy, with an area under the curve (AUC) of 0.966 (95%CI: 0.952-0.979). Meanwhile, the cutoff value was 1.315 mg/L, and the Youden index was 0.826, with the sensitivity of 94.3% and specificity of 88.4%. Conclusion: Serum cystatin C can be used as an important laboratory indicator to evaluate the renal impairment in PDR patients.
Collapse
|
231
|
Zhang M. P–673 A visualized clinical model predicting cumulative pregnancy rate after IVF-ET: a real-world study. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.672] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
How is the cumulative pregnancy probability of individual patients after IVF-ET,could we develop a visualized clinical model to predict it based on patient’s characteristics?
Summary answer
The visualized clinical mode incorporates five items of female age, number of oocytes, antral follicle count, endometrium thickness and basal FSH level.
What is known already
Many factors can result in infertility, prognosis prediction is clinically relevant for making the right therapeutic strategy while avoiding overtreatment. It is also helpful in counselling, making the patient aware of possible treatment duration and estimated expense and managing patient’s expectation. Visualized clinical mode and accurate prediction would also be helpful in designing clinical trials to evaluate new treatments.
Study design, size, duration
We conducted a retrospective analysis of a single-center database using prospectively collected data from women who underwent IVF/ICSI treatment from January 2013 to December 2015, All the participants were followed up for at least 2 years, 3538 IVF-ET cycles were included in the study.A total of 3538 IVF/ICSI cycles were included in the study.
Participants/materials, setting, methods
Data from a total of 2312 IVF/ICSI cycles from January 2013 to December 2014 were randomly split into training dataset (1550, 67%) and internal validation dataset (762, 33%). A total of 1226 IVF/ICSI cycles in 2015 was applied to external validation dataset (temporal validation)
Main results and the role of chance
Multivariable logistic regression model combined with restricted cubic splines function was used to test independent prognostic factors and estimate their effects on treatment outcome for patients treated with IVF/ICSI. Female age, number of oocytes retrieved, AFC, endometrium thickness and basal FSH were included the final model. The above model was used to calculate prediction scores for all women in the training and validation datasets. The C-index was 0.693 (95% CI: 0.692∼0.695) in training sets, 0.689 in internal validation sets and 0.710 in external validation sets, which denotes a good performance. Calibration curves suggest excellent model calibration, with an ideal agreement between the prediction and actual observation . The DCA showed that if the threshold probability is between 0 and 0.7, using the nomogram derived in the present study to predict cumulative pregnancy provided a greater benefit than either thetreat-all or the treat-none strategy.
Limitations, reasons for caution
it was a retrospective, single-center study.In the future, prospective, randomized controlled, multicenter clinical studies will be designed.
Wider implications of the findings: The visualized nomogram model provides great predictive value for infertility patients in their first IVF/ICSI cycle, and predicts the pregnancy probability of individuals ,and could help clinicians improving clinical counselling.
Trial registration number
Not applicable
Collapse
|
232
|
Wu J, Yuan M, Wu Y, Zhang M. [Sacral nerve magnetic stimulation combined with rehabilitation training in the treatment of primary nocturnal enuresis in children]. ZHONGHUA ER KE ZA ZHI = CHINESE JOURNAL OF PEDIATRICS 2021; 59:684-688. [PMID: 34333922 DOI: 10.3760/cma.j.cn112140-20210329-00264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To explore the clinical value of sacral magnetic stimulation (SMS) combined with rehabilitation training in the treatment of primary nocturnal enuresis (PNE) in children. Methods: The clinical data of 57 children with PNE admitted to the Department of Rehabilitation Xuzhou Rehabilitation Hospital, Xuzhou Central Hospital and Xuzhou Children's Hospital from October 2019 to September 2020 were collected and analyzed. The children were divided prospectively into observation group and control group by using random number table method. Bladder function training, awakening training and life and psychological intervention were performed in both groups, while the observation group was treated with SMS based on the above treatment methods. Before and after treatment, the degree and the frequency of enuresis (normal, mild, moderate, severe), therapeutic evaluation and bladder volume were compared. Chi-square test and T test were used for comparison between the two groups. Results: Finally, 28 cases in the observation group and 29 cases in the control group were included. There was no significant difference in age, sex, degree and of frequency enuresis of children between the two groups (all P>0.05).The degree of enuresis in the observation group after 1 month of treatment was better than that in the control group (12 vs. 7 cases, 8 vs. 8 cases, 5 vs. 9 cases, 3 vs. 5 cases, χ2=-2.269, P=0.030). Enuresis times in observation group was lower than that in the control group [(4.2±1.8) vs. (8.1±2.0), t=4.475, P<0.01). The total effective rate and bladder capacity of efficacy evaluation were higher than those of control group [82%(23/28) vs. 48%(14/29), (225±25) vs. (199±21) ml, Z=11.238, t=-2.249, both P<0.05]. Conclusions: SMS is an effective method for the treatment of PNE in children, which can reduce the degree and frequency of enuresis in children, increase the bladder volume and improve the total effective rate of treatment. It is worthy of clinical promotion and application.
Collapse
|
233
|
Guo YK, Zhang M, Wang Q, Chen ZY, Dong GZ, Yao T, Xu Y. [Influence of neuroimaging markers of chronic cerebral small vessel disease on prognosis of patients with cardioembolic stroke]. ZHONGHUA YI XUE ZA ZHI 2021; 101:2333-2336. [PMID: 34333951 DOI: 10.3760/cma.j.cn112137-20201216-03370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Data of 189 patients with first-ever cardioembolic stroke (CES) hospitalized in the Second People's Hospital of Changzhou from June 2014 to September 2019 were retrospectively analyzed. The neuoimaging markers of chronic small vessel disease (cSVDm) were evaluated and their total burden (0-3 points) was calculated. At 90 d after onset, 65 patients had poor prognosis. Regression analysis showed that the total cSVDm burden score was an independent riskfactor for the poor prognosis(OR=1.754, 95%CI:1.137-2.707, P=0.011).
Collapse
|
234
|
Zhang M, Sheng C, You H, Cai M, Gao J, Cheng X, Sheng H, Qu S. Comparing the bone mineral density among male patients with latent autoimmune diabetes and classical type 1 and type 2 diabetes, and exploring risk factors for osteoporosis. J Endocrinol Invest 2021; 44:1659-1665. [PMID: 33387352 DOI: 10.1007/s40618-020-01472-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 11/21/2020] [Indexed: 12/21/2022]
Abstract
AIMS This study aimed to compare the bone mineral densities (BMDs) among male patients with latent autoimmune diabetes in adults (LADA), classical type 1 diabetes (T1DM), and type 2 diabetes (T2DM), and to examine the risk factors for developing low BMD in these patients. PATIENTS AND METHODS Between January 2017 and October 2020, a total of 57, 67, and 223 male patients with LADA, classical T1DM, and T2DM, respectively, were recruited from the endocrinology department of Shanghai Tenth People's Hospital. Hormonal markers of bone metabolism, lipid profiles, uric acid, glycosylated hemoglobin A1c (HbA1c), and beta-cell function were measured using blood samples. BMD was measured at the lumbar spine, femoral neck, and right hip by dual-energy X-ray absorptiometry. RESULTS The mean BMD values from all three skeletal sites in male patients with LADA were comparable to those with classical T1DM but were much lower than those with T2DM. After adjusting for confounding factors, multiple linear regression analysis demonstrated that in all male patients with diabetes, body mass index (BMI), uric acid, and fasting C-peptide showed significant positive associations with BMD at all three skeletal sites; however, osteocalcin showed a negative association at all three sites. CONCLUSIONS Compared with male patients with T2DM, lower BMDs were observed in patients with LADA and T1DM. Low BMI, uric acid, C-peptide levels, and high osteocalcin levels are risk factors for developing low BMD in male patients with diabetes.
Collapse
|
235
|
Acklin-Wehnert S, Zhang M, Gillenwater J, Du W, Patra M, Yu J, Xia F. OC-0182 SIRT2 promotes murine melanoma progression through natural killer cell inhibition. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)06797-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
236
|
Aad G, Abbott B, Abbott DC, Abed Abud A, Abeling K, Abhayasinghe DK, Abidi SH, AbouZeid OS, Abraham NL, Abramowicz H, Abreu H, Abulaiti Y, Acharya BS, Achkar B, Adam L, Adam Bourdarios C, Adamczyk L, Adamek L, Adelman J, Adiguzel A, Adorni S, Adye T, Affolder AA, Afik Y, Agapopoulou C, Agaras MN, Aggarwal A, Agheorghiesei C, Aguilar-Saavedra JA, Ahmad A, Ahmadov F, Ahmed WS, Ai X, Aielli G, Akatsuka S, Akbiyik M, Åkesson TPA, Akilli E, Akimov AV, Al Khoury K, Alberghi GL, Albert J, Alconada Verzini MJ, Alderweireldt S, Aleksa M, Aleksandrov IN, Alexa C, Alexopoulos T, Alfonsi A, Alfonsi F, Alhroob M, Ali B, Ali S, Aliev M, Alimonti G, Allaire C, Allbrooke BMM, Allport PP, Aloisio A, Alonso F, Alpigiani C, Alunno Camelia E, Alvarez Estevez M, Alviggi MG, Amaral Coutinho Y, Ambler A, Ambroz L, Amelung C, Amidei D, Amor Dos Santos SP, Amoroso S, Amrouche CS, Anastopoulos C, Andari N, Andeen T, Anders JK, Andrean SY, Andreazza A, Andrei V, Anelli CR, Angelidakis S, Angerami A, Anisenkov AV, Annovi A, Antel C, Anthony MT, Antipov E, Antonelli M, Antrim DJA, Anulli F, Aoki M, Aparisi Pozo JA, Aparo MA, Aperio Bella L, Aranzabal N, Araujo Ferraz V, Araujo Pereira R, Arcangeletti C, Arce ATH, Arguin JF, Argyropoulos S, Arling JH, Armbruster AJ, Armstrong A, Arnaez O, Arnold H, Arrubarrena Tame ZP, Artoni G, Asada H, Asai K, Asai S, Asawatavonvanich T, Asbah N, Asimakopoulou EM, Asquith L, Assahsah J, Assamagan K, Astalos R, Atkin RJ, Atkinson M, Atlay NB, Atmani H, Atmasiddha PA, Augsten K, Austrup VA, Avolio G, Ayoub MK, Azuelos G, Babal D, Bachacou H, Bachas K, Backman F, Bagnaia P, Bahmani M, Bahrasemani H, Bailey AJ, Bailey VR, Baines JT, Bakalis C, Baker OK, Bakker PJ, Bakos E, Bakshi Gupta D, Balaji S, Balasubramanian R, Baldin EM, Balek P, Balli F, Balunas WK, Balz J, Banas E, Bandieramonte M, Bandyopadhyay A, Barak L, Barbe WM, Barberio EL, Barberis D, Barbero M, Barbour G, Barillari T, Barisits MS, Barkeloo J, Barklow T, Barnett BM, Barnett RM, Barnovska-Blenessy Z, Baroncelli A, Barone G, Barr AJ, Barranco Navarro L, Barreiro F, Barreiro Guimarães da Costa J, Barron U, Barsov S, Bartels F, Bartoldus R, Bartolini G, Barton AE, Bartos P, Basalaev A, Basan A, Bassalat A, Basso MJ, Basson CR, Bates RL, Batlamous S, Batley JR, Batool B, Battaglia M, Bauce M, Bauer F, Bauer P, Bawa HS, Bayirli A, Beacham JB, Beau T, Beauchemin PH, Becherer F, Bechtle P, Beck HP, Becker K, Becot C, Beddall AJ, Bednyakov VA, Bee CP, Beermann TA, Begalli M, Begel M, Behera A, Behr JK, Beisiegel F, Belfkir M, Bella G, Bellagamba L, Bellerive A, Bellos P, Beloborodov K, Belotskiy K, Belyaev NL, Benchekroun D, Benekos N, Benhammou Y, Benjamin DP, Benoit M, Bensinger JR, Bentvelsen S, Beresford L, Beretta M, Berge D, Bergeaas Kuutmann E, Berger N, Bergmann B, Bergsten LJ, Beringer J, Berlendis S, Bernardi G, Bernius C, Bernlochner FU, Berry T, Berta P, Berthold A, Bertram IA, Bessidskaia Bylund O, Bethke S, Betti A, Bevan AJ, Bhatta S, Bhattacharya DS, Bhattarai P, Bhopatkar VS, Bi R, Bianchi RM, Biebel O, Biedermann D, Bielski R, Bierwagen K, Biesuz NV, Biglietti M, Billoud TRV, Bindi M, Bingul A, Bini C, Biondi S, Birch-Sykes CJ, Birman M, Bisanz T, Biswal JP, Biswas D, Bitadze A, Bittrich C, Bjørke K, Blazek T, Bloch I, Blocker C, Blue A, Blumenschein U, Bobbink GJ, Bobrovnikov VS, Bogavac D, Bogdanchikov AG, Bohm C, Boisvert V, Bokan P, Bold T, Bomben M, Bona M, Bonilla JS, Boonekamp M, Booth CD, Borbély AG, Borecka-Bielska HM, Borgna LS, Borisov A, Borissov G, Bortoletto D, Boscherini D, Bosman M, Bossio Sola JD, Bouaouda K, Boudreau J, Bouhova-Thacker EV, Boumediene D, Bouquet R, Boveia A, Boyd J, Boye D, Boyko IR, Bozson AJ, Bracinik J, Brahimi N, Brandt G, Brandt O, Braren F, Brau B, Brau JE, Breaden Madden WD, Brendlinger K, Brener R, Brenner L, Brenner R, Bressler S, Brickwedde B, Briglin DL, Britton D, Britzger D, Brock I, Brock R, Brooijmans G, Brooks WK, Brost E, Bruckman de Renstrom PA, Brüers B, Bruncko D, Bruni A, Bruni G, Bruschi M, Bruscino N, Bryngemark L, Buanes T, Buat Q, Buchholz P, Buckley AG, Budagov IA, Bugge MK, Bulekov O, Bullard BA, Burch TJ, Burdin S, Burgard CD, Burger AM, Burghgrave B, Burr JTP, Burton CD, Burzynski JC, Büscher V, Buschmann E, Bussey PJ, Butler JM, Buttar CM, Butterworth JM, Buttinger W, Buxo Vazquez CJ, Buzykaev AR, Cabras G, Cabrera Urbán S, Caforio D, Cai H, Cairo VMM, Cakir O, Calace N, Calafiura P, Calderini G, Calfayan P, Callea G, Caloba LP, Caltabiano A, Calvente Lopez S, Calvet D, Calvet S, Calvet TP, Calvetti M, Camacho Toro R, Camarda S, Camarero Munoz D, Camarri P, Camerlingo MT, Cameron D, Camincher C, Campanelli M, Camplani A, Canale V, Canesse A, Cano Bret M, Cantero J, Cao Y, Capua M, Cardarelli R, Cardillo F, Carducci G, Carli T, Carlino G, Carlson BT, Carlson EM, Carminati L, Carney RMD, Caron S, Carquin E, Carrá S, Carratta G, Carter JWS, Carter TM, Casado MP, Casha AF, Castiglia EG, Castillo FL, Castillo Garcia L, Castillo Gimenez V, Castro NF, Catinaccio A, Catmore JR, Cattai A, Cavaliere V, Cavasinni V, Celebi E, Celli F, Cerny K, Cerqueira AS, Cerri A, Cerrito L, Cerutti F, Cervelli A, Cetin SA, Chadi Z, Chakraborty D, Chan J, Chan WS, Chan WY, Chapman JD, Chargeishvili B, Charlton DG, Charman TP, Chatterjee M, Chau CC, Chekanov S, Chekulaev SV, Chelkov GA, Chen B, Chen C, Chen CH, Chen H, Chen H, Chen J, Chen J, Chen J, Chen S, Chen SJ, Chen X, Chen Y, Chen YH, Cheng HC, Cheng HJ, Cheplakov A, Cheremushkina E, Cherkaoui El Moursli R, Cheu E, Cheung K, Chevalérias TJA, Chevalier L, Chiarella V, Chiarelli G, Chiodini G, Chisholm AS, Chitan A, Chiu I, Chiu YH, Chizhov MV, Choi K, Chomont AR, Chou Y, Chow YS, Christopher LD, Chu MC, Chu X, Chudoba J, Chwastowski JJ, Cieri D, Ciesla KM, Cindro V, Cioară IA, Ciocio A, Cirotto F, Citron ZH, Citterio M, Ciubotaru DA, Ciungu BM, Clark A, Clark PJ, Clawson SE, Clement C, Clissa L, Coadou Y, Cobal M, Coccaro A, Cochran J, Coelho Lopes De Sa R, Cohen H, Coimbra AEC, Cole B, Collot J, Conde Muiño P, Connell SH, Connelly IA, Conventi F, Cooper-Sarkar AM, Cormier F, Corpe LD, Corradi M, Corrigan EE, Corriveau F, Costa MJ, Costanza F, Costanzo D, Cowan G, Cowley JW, Crane J, Cranmer K, Creager RA, Crépé-Renaudin S, Crescioli F, Cristinziani M, Cristoforetti M, Croft V, Crosetti G, Cueto A, Cuhadar Donszelmann T, Cui H, Cukierman AR, Cunningham WR, Czekierda S, Czodrowski P, Czurylo MM, Da Cunha Sargedas De Sousa MJ, Da Fonseca Pinto JV, Da Via C, Dabrowski W, Dachs F, Dado T, Dahbi S, Dai T, Dallapiccola C, Dam M, D'amen G, D'Amico V, Damp J, Dandoy JR, Daneri MF, Danninger M, Dao V, Darbo G, Dartsi O, Dattagupta A, D'Auria S, David C, Davidek T, Davis DR, Dawson I, De K, De Asmundis R, De Beurs M, De Castro S, De Groot N, de Jong P, De la Torre H, De Maria A, De Pedis D, De Salvo A, De Sanctis U, De Santis M, De Santo A, De Vivie De Regie JB, Dedovich DV, Deiana AM, Del Peso J, Delabat Diaz Y, Delgove D, Deliot F, Delitzsch CM, Della Pietra M, Della Volpe D, Dell'Acqua A, Dell'Asta L, Delmastro M, Delporte C, Delsart PA, Demers S, Demichev M, Demontigny G, Denisov SP, D'Eramo L, Derendarz D, Derkaoui JE, Derue F, Dervan P, Desch K, Dette K, Deutsch C, Deviveiros PO, Di Bello FA, Di Ciaccio A, Di Ciaccio L, Di Donato C, Di Girolamo A, Di Gregorio G, Di Luca A, Di Micco B, Di Nardo R, Di Sipio R, Diaconu C, Dias FA, Dias Do Vale T, Diaz MA, Diaz Capriles FG, Dickinson J, Didenko M, Diehl EB, Dietrich J, Díez Cornell S, Diez Pardos C, Dimitrievska A, Ding W, Dingfelder J, Dittmeier SJ, Dittus F, Djama F, Djobava T, Djuvsland JI, Do Vale MAB, Dobre M, Dodsworth D, Doglioni C, Dolejsi J, Dolezal Z, Donadelli M, Dong B, Donini J, D'onofrio A, D'Onofrio M, Dopke J, Doria A, Dova MT, Doyle AT, Drechsler E, Dreyer E, Dreyer T, Drobac AS, Du D, du Pree TA, Duan Y, Dubinin F, Dubovsky M, Dubreuil A, Duchovni E, Duckeck G, Ducu OA, Duda D, Dudarev A, Dudder AC, D'uffizi M, Duflot L, Dührssen M, Dülsen C, Dumancic M, Dumitriu AE, Dunford M, Dungs S, Duperrin A, Duran Yildiz H, Düren M, Durglishvili A, Dutta B, Duvnjak D, Dyckes GI, Dyndal M, Dysch S, Dziedzic BS, Eggleston MG, Eifert T, Eigen G, Einsweiler K, Ekelof T, El Jarrari H, El Moussaouy A, Ellajosyula V, Ellert M, Ellinghaus F, Elliot AA, Ellis N, Elmsheuser J, Elsing M, Emeliyanov D, Emerman A, Enari Y, Erdmann J, Ereditato A, Erland PA, Errenst M, Escalier M, Escobar C, Estrada Pastor O, Etzion E, Evans G, Evans H, Evans MO, Ezhilov A, Fabbri F, Fabbri L, Fabiani V, Facini G, Fakhrutdinov RM, Falciano S, Falke PJ, Falke S, Faltova J, Fang Y, Fang Y, Fanourakis G, Fanti M, Faraj M, Farbin A, Farilla A, Farina EM, Farooque T, Farrington SM, Farthouat P, Fassi F, Fassouliotis D, Faucci Giannelli M, Fawcett WJ, Fayard L, Fedin OL, Fehr A, Feickert M, Feligioni L, Fell A, Feng C, Feng M, Fenton MJ, Fenyuk AB, Ferguson SW, Ferrando J, Ferrari A, Ferrari P, Ferrari R, Ferrere D, Ferretti C, Fiedler F, Filipčič A, Filthaut F, Finelli KD, Fiolhais MCN, Fiorini L, Fischer F, Fischer J, Fisher WC, Fitschen T, Fleck I, Fleischmann P, Flick T, Flierl BM, Flores L, Flores Castillo LR, Follega FM, Fomin N, Foo JH, Forcolin GT, Forland BC, Formica A, Förster FA, Forti AC, Fortin E, Foti MG, Fournier D, Fox H, Francavilla P, Francescato S, Franchini M, Franchino S, Francis D, Franco L, Franconi L, Franklin M, Frattari G, Freeman PM, Freund B, Freund WS, Freundlich EM, Frizzell DC, Froidevaux D, Frost JA, Fujimoto M, Fullana Torregrosa E, Fusayasu T, Fuster J, Gabrielli A, Gabrielli A, Gadow P, Gagliardi G, Gagnon LG, Gallardo GE, Gallas EJ, Gallop BJ, Gamboa Goni R, Gan KK, Ganguly S, Gao J, Gao Y, Gao YS, Garay Walls FM, García C, García Navarro JE, García Pascual JA, Garcia-Sciveres M, Gardner RW, Gargiulo S, Garner CA, Garonne V, Gasiorowski SJ, Gaspar P, Gaudio G, Gauzzi P, Gavrilenko IL, Gavrilyuk A, Gay C, Gaycken G, Gazis EN, Geanta AA, Gee CM, Gee CNP, Geisen J, Geisen M, Gemme C, Genest MH, Geng C, Gentile S, George S, Geralis T, Gerlach LO, Gessinger-Befurt P, Gessner G, Ghasemi Bostanabad M, Ghneimat M, Ghosh A, Ghosh A, Giacobbe B, Giagu S, Giangiacomi N, Giannetti P, Giannini A, Giannini G, Gibson SM, Gignac M, Gil DT, Gilbert BJ, Gillberg D, Gilles G, Gillwald NEK, Gingrich DM, Giordani MP, Giraud PF, Giugliarelli G, Giugni D, Giuli F, Gkaitatzis S, Gkialas I, Gkougkousis EL, Gkountoumis P, Gladilin LK, Glasman C, Gledhill GR, Gnesi I, Goblirsch-Kolb M, Godin D, Goldfarb S, Golling T, Golubkov D, Gomes A, Goncalves Gama R, Gonçalo R, Gonella G, Gonella L, Gongadze A, Gonnella F, Gonski JL, González de la Hoz S, Gonzalez Fernandez S, Gonzalez Lopez R, Gonzalez Renteria C, Gonzalez Suarez R, Gonzalez-Sevilla S, Gonzalvo Rodriguez GR, Goossens L, Gorasia NA, Gorbounov PA, Gordon HA, Gorini B, Gorini E, Gorišek A, Goshaw AT, Gostkin MI, Gottardo CA, Gouighri M, Goussiou AG, Govender N, Goy C, Grabowska-Bold I, Gramstad E, Grancagnolo S, Grandi M, Gratchev V, Gravila PM, Gravili FG, Gray C, Gray HM, Grefe C, Gregor IM, Grenier P, Grevtsov K, Grieco C, Grieser NA, Grillo AA, Grimm K, Grinstein S, Grivaz JF, Groh S, Gross E, Grosse-Knetter J, Grout ZJ, Grud C, Grummer A, Grundy JC, Guan L, Guan W, Gubbels C, Guenther J, Guerrero Rojas JGR, Guescini F, Guest D, Gugel R, Guida A, Guillemin T, Guindon S, Guo J, Guo Z, Gupta R, Gurbuz S, Gustavino G, Guth M, Gutierrez P, Gutierrez Zagazeta LF, Gutschow C, Guyot C, Gwenlan C, Gwilliam CB, Haaland ES, Haas A, Haber C, Hadavand HK, Hadef A, Haleem M, Haley J, Hall JJ, Halladjian G, Hallewell GD, Hamano K, Hamdaoui H, Hamer M, Hamity GN, Han K, Han L, Han L, Han S, Han YF, Hanagaki K, Hance M, Hank MD, Hankache R, Hansen E, Hansen JB, Hansen JD, Hansen MC, Hansen PH, Hanson EC, Hara K, Harenberg T, Harkusha S, Harrison PF, Hartman NM, Hartmann NM, Hasegawa Y, Hasib A, Hassani S, Haug S, Hauser R, Havranek M, Hawkes CM, Hawkings RJ, Hayashida S, Hayden D, Hayes C, Hayes RL, Hays CP, Hays JM, Hayward HS, Haywood SJ, He F, He Y, Heath MP, Hedberg V, Heggelund AL, Hehir ND, Heidegger C, Heidegger KK, Heidorn WD, Heilman J, Heim S, Heim T, Heinemann B, Heinlein JG, Heinrich JJ, Heinrich L, Hejbal J, Helary L, Held A, Hellesund S, Helling CM, Hellman S, Helsens C, Henderson RCW, Henkelmann L, Henriques Correia AM, Herde H, Hernández Jiménez Y, Herr H, Herrmann MG, Herrmann T, Herten G, Hertenberger R, Hervas L, Hessey NP, Hibi H, Higashino S, Higón-Rodriguez E, Hildebrand K, Hill JC, Hill KK, Hiller KH, Hillier SJ, Hils M, Hinchliffe I, Hinterkeuser F, Hirose M, Hirose S, Hirschbuehl D, Hiti B, Hladik O, Hobbs J, Hobincu R, Hod N, Hodgkinson MC, Hoecker A, Hohn D, Hohov D, Holm T, Holmes TR, Holzbock M, Hommels LBAH, Hong TM, Honig JC, Hönle A, Hooberman BH, Hopkins WH, Horii Y, Horn P, Horyn LA, Hou S, Howarth J, Hoya J, Hrabovsky M, Hrynevich A, Hryn'ova T, Hsu PJ, Hsu SC, Hu Q, Hu S, Hu YF, Huang DP, Huang X, Huang Y, Huang Y, Hubacek Z, Hubaut F, Huebner M, Huegging F, Huffman TB, Huhtinen M, Hulsken R, Hunter RFH, Huseynov N, Huston J, Huth J, Hyneman R, Hyrych S, Iacobucci G, Iakovidis G, Ibragimov I, Iconomidou-Fayard L, Iengo P, Ignazzi R, Iguchi R, Iizawa T, Ikegami Y, Ilic N, Imam H, Introzzi G, Iodice M, Iordanidou K, Ippolito V, Isacson MF, Ishino M, Islam W, Issever C, Istin S, Iturbe Ponce JM, Iuppa R, Ivina A, Izen JM, Izzo V, Jacka P, Jackson P, Jacobs RM, Jaeger BP, Jäkel G, Jakobi KB, Jakobs K, Jakoubek T, Jamieson J, Janas KW, Jansky R, Janus PA, Jarlskog G, Jaspan AE, Javadov N, Javůrek T, Javurkova M, Jeanneau F, Jeanty L, Jejelava J, Jenni P, Jézéquel S, Jia J, Jia X, Jia Z, Jiang Y, Jiggins S, Jimenez Morales FA, Jimenez Pena J, Jin S, Jinaru A, Jinnouchi O, Jivan H, Johansson P, Johns KA, Johnson CA, Jones E, Jones RWL, Jones SD, Jones TJ, Jovicevic J, Ju X, Junggeburth JJ, Juste Rozas A, Kaczmarska A, Kado M, Kagan H, Kagan M, Kahn A, Kahra C, Kaji T, Kajomovitz E, Kalderon CW, Kaluza A, Kamenshchikov A, Kaneda M, Kang NJ, Kang S, Kano Y, Kanzaki J, Kar D, Karava K, Kareem MJ, Karkanias I, Karpov SN, Karpova ZM, Kartvelishvili V, Karyukhin AN, Kasimi E, Kato C, Katzy J, Kawade K, Kawagoe K, Kawaguchi T, Kawamoto T, Kawamura G, Kay EF, Kaya FI, Kazakos S, Kazanin VF, Keaveney JM, Keeler R, Keller JS, Kelsey D, Kempster JJ, Kendrick J, Kennedy KE, Kepka O, Kersten S, Kerševan BP, Ketabchi Haghighat S, Khalil-Zada F, Khandoga M, Khanov A, Kharlamov AG, Kharlamova T, Khoda EE, Khoo TJ, Khoriauli G, Khramov E, Khubua J, Kido S, Kiehn M, Kilgallon A, Kim E, Kim YK, Kimura N, Kirchhoff A, Kirchmeier D, Kirk J, Kiryunin AE, Kishimoto T, Kisliuk DP, Kitali V, Kitsaki C, Kivernyk O, Klapdor-Kleingrothaus T, Klassen M, Klein C, Klein L, Klein MH, Klein M, Klein U, Klimek P, Klimentov A, Klimpel F, Klingl T, Klioutchnikova T, Klitzner FF, Kluit P, Kluth S, Kneringer E, Knue A, Kobayashi D, Kobel M, Kocian M, Kodama T, Kodys P, Koeck DM, Koenig PT, Koffas T, Köhler NM, Kolb M, Koletsou I, Komarek T, Köneke K, Kong AXY, Kono T, Konstantinides V, Konstantinidis N, Konya B, Kopeliansky R, Koperny S, Korcyl K, Kordas K, Koren G, Korn A, Korolkov I, Korolkova EV, Korotkova N, Kortner O, Kortner S, Kostyukhin VV, Kotsokechagia A, Kotwal A, Koulouris A, Kourkoumeli-Charalampidi A, Kourkoumelis C, Kourlitis E, Kowalewski R, Kozanecki W, Kozhin AS, Kramarenko VA, Kramberger G, Krasnopevtsev D, Krasny MW, Krasznahorkay A, Kremer JA, Kretzschmar J, Kreul K, Krieger P, Krieter F, Krishnamurthy S, Krishnan A, Krivos M, Krizka K, Kroeninger K, Kroha H, Kroll J, Kroll J, Krowpman KS, Kruchonak U, Krüger H, Krumnack N, Kruse MC, Krzysiak JA, Kubota A, Kuchinskaia O, Kuday S, Kuechler D, Kuechler JT, Kuehn S, Kuhl T, Kukhtin V, Kulchitsky Y, Kuleshov S, Kulinich YP, Kumar M, Kuna M, Kupco A, Kupfer T, Kuprash O, Kurashige H, Kurchaninov LL, Kurochkin YA, Kurova A, Kurth MG, Kuwertz ES, Kuze M, Kvam AK, Kvita J, Kwan T, Lacasta C, Lacava F, Lack DPJ, Lacker H, Lacour D, Ladygin E, Lafaye R, Laforge B, Lagouri T, Lai S, Lakomiec IK, Lambert JE, Lammers S, Lampl W, Lampoudis C, Lançon E, Landgraf U, Landon MPJ, Lang VS, Lange JC, Langenberg RJ, Lankford AJ, Lanni F, Lantzsch K, Lanza A, Lapertosa A, Laporte JF, Lari T, Lasagni Manghi F, Lassnig M, Latonova V, Lau TS, Laudrain A, Laurier A, Lavorgna M, Lawlor SD, Lazzaroni M, Le B, Lebedev A, LeBlanc M, LeCompte T, Ledroit-Guillon F, Lee ACA, Lee CA, Lee GR, Lee L, Lee SC, Lee S, Lefebvre B, Lefebvre HP, Lefebvre M, Leggett C, Lehmann K, Lehmann N, Lehmann Miotto G, Leight WA, Leisos A, Leite MAL, Leitgeb CE, Leitner R, Leney KJC, Lenz T, Leone S, Leonidopoulos C, Leopold A, Leroy C, Les R, Lester CG, Levchenko M, Levêque J, Levin D, Levinson LJ, Lewis DJ, Li B, Li B, Li CQ, Li F, Li H, Li H, Li J, Li K, Li L, Li M, Li QY, Li S, Li X, Li Y, Li Z, Li Z, Li Z, Li Z, Liang Z, Liberatore M, Liberti B, Lie K, Lin CY, Lin K, Linck RA, Lindley RE, Lindon JH, Linss A, Lionti AL, Lipeles E, Lipniacka A, Liss TM, Lister A, Little JD, Liu B, Liu BX, Liu JB, Liu JKK, Liu K, Liu M, Liu MY, Liu P, Liu X, Liu Y, Liu Y, Liu YL, Liu YW, Livan M, Lleres A, Llorente Merino J, Lloyd SL, Lobodzinska EM, Loch P, Loffredo S, Lohse T, Lohwasser K, Lokajicek M, Long JD, Long RE, Longarini I, Longo L, Longo R, Lopez Paz I, Lopez Solis A, Lorenz J, Lorenzo Martinez N, Lory AM, Lösle A, Lou X, Lou X, Lounis A, Love J, Love PA, Lozano Bahilo JJ, Lu M, Lu S, Lu YJ, Lubatti HJ, Luci C, Lucio Alves FL, Lucotte A, Luehring F, Luise I, Luminari L, Lund-Jensen B, Luongo NA, Lutz MS, Lynn D, Lyons H, Lysak R, Lytken E, Lyu F, Lyubushkin V, Lyubushkina T, Ma H, Ma LL, Ma Y, Mac Donell DM, Maccarrone G, Macdonald CM, MacDonald JC, Machado Miguens J, Madar R, Mader WF, Madugoda Ralalage Don M, Madysa N, Maeda J, Maeno T, Maerker M, Magerl V, Magro J, Mahon DJ, Maidantchik C, Maio A, Maj K, Majersky O, Majewski S, Makovec N, Malaescu B, Malecki P, Maleev VP, Malek F, Malito D, Mallik U, Malone C, Maltezos S, Malyukov S, Mamuzic J, Mancini G, Mandalia JP, Mandić I, Manhaes de Andrade Filho L, Maniatis IM, Manjarres Ramos J, Mankinen KH, Mann A, Manousos A, Mansoulie B, Manthos I, Manzoni S, Marantis A, Marchese L, Marchiori G, Marcisovsky M, Marcoccia L, Marcon C, Marjanovic M, Marshall Z, Martensson MUF, Marti-Garcia S, Martin TA, Martin VJ, Martin Dit Latour B, Martinelli L, Martinez M, Martinez Agullo P, Martinez Outschoorn VI, Martin-Haugh S, Martoiu VS, Martyniuk AC, Marzin A, Maschek SR, Masetti L, Mashimo T, Mashinistov R, Masik J, Maslennikov AL, Massa L, Massarotti P, Mastrandrea P, Mastroberardino A, Masubuchi T, Matakias D, Mathisen T, Matic A, Matsuzawa N, Maurer J, Maček B, Maximov DA, Mazini R, Maznas I, Mazza SM, Mc Ginn C, Mc Gowan JP, Mc Kee SP, McCarthy TG, McCormack WP, McDonald EF, McDougall AE, Mcfayden JA, Mchedlidze G, McKay MA, McLean KD, McMahon SJ, McNamara PC, McNicol CJ, McPherson RA, Mdhluli JE, Meadows ZA, Meehan S, Megy T, Mehlhase S, Mehta A, Meirose B, Melini D, Mellado Garcia BR, Meloni F, Melzer A, Mendes Gouveia ED, Mendes Jacques Da Costa AM, Meng HY, Meng L, Menke S, Meoni E, Mergelmeyer S, Merkt SAM, Merlassino C, Mermod P, Merola L, Meroni C, Merz G, Meshkov O, Meshreki JKR, Metcalfe J, Mete AS, Meyer C, Meyer JP, Michetti M, Middleton RP, Mijović L, Mikenberg G, Mikestikova M, Mikuž M, Mildner H, Milic A, Milke CD, Miller DW, Miller LS, Milov A, Milstead DA, Minaenko AA, Minashvili IA, Mince L, Mincer AI, Mindur B, Mineev M, Minegishi Y, Mino Y, Mir LM, Mironova M, Mitani T, Mitrevski J, Mitsou VA, Mittal M, Miu O, Miucci A, Miyagawa PS, Mizukami A, Mjörnmark JU, Mkrtchyan T, Mlynarikova M, Moa T, Mobius S, Mochizuki K, Moder P, Mogg P, Mohapatra S, Mokgatitswane G, Mondal B, Mondal S, Mönig K, Monnier E, Montalbano A, Montejo Berlingen J, Montella M, Monticelli F, Morange N, Moreira De Carvalho AL, Moreno Llácer M, Moreno Martinez C, Morettini P, Morgenstern M, Morgenstern S, Mori D, Morii M, Morinaga M, Morisbak V, Morley AK, Morris AP, Morvaj L, Moschovakos P, Moser B, Mosidze M, Moskalets T, Moskvitina P, Moss J, Moyse EJW, Muanza S, Mueller J, Muenstermann D, Mullier GA, Mullin JJ, Mungo DP, Munoz Martinez JL, Munoz Sanchez FJ, Murin P, Murray WJ, Murrone A, Muse JM, Muškinja M, Mwewa C, Myagkov AG, Myers AA, Myers G, Myers J, Myska M, Nachman BP, Nackenhorst O, Nag AN, Nagai K, Nagano K, Nagle JL, Nagy E, Nairz AM, Nakahama Y, Nakamura K, Nanjo H, Napolitano F, Naranjo Garcia RF, Narayan R, Naryshkin I, Naseri M, Naumann T, Navarro G, Navarro-Gonzalez J, Nechaeva PY, Nechansky F, Neep TJ, Negri A, Negrini M, Nellist C, Nelson C, Nelson ME, Nemecek S, Nessi M, Neubauer MS, Neuhaus F, Neumann M, Newhouse R, Newman PR, Ng CW, Ng YS, Ng YWY, Ngair B, Nguyen HDN, Nguyen Manh T, Nibigira E, Nickerson RB, Nicolaidou R, Nielsen DS, Nielsen J, Niemeyer M, Nikiforou N, Nikolaenko V, Nikolic-Audit I, Nikolopoulos K, Nilsson P, Nindhito HR, Nisati A, Nishu N, Nisius R, Nitsche I, Nitta T, Nobe T, Noel DL, Noguchi Y, Nomidis I, Nomura MA, Norisam RRB, Novak J, Novak T, Novgorodova O, Novotny R, Nozka L, Ntekas K, Nurse E, Oakham FG, Ocariz J, Ochi A, Ochoa I, Ochoa-Ricoux JP, O'Connor K, Oda S, Odaka S, Oerdek S, Ogrodnik A, Oh A, Ohm CC, Oide H, Oishi R, Ojeda ML, Okazaki Y, O'Keefe MW, Okumura Y, Olariu A, Oleiro Seabra LF, Olivares Pino SA, Oliveira Damazio D, Oliver JL, Olsson MJR, Olszewski A, Olszowska J, Öncel ÖO, O'Neil DC, O'neill AP, Onofre A, Onyisi PUE, Oppen H, Oreamuno Madriz RG, Oreglia MJ, Orellana GE, Orestano D, Orlando N, Orr RS, O'Shea V, Ospanov R, Otero Y Garzon G, Otono H, Ott PS, Ottino GJ, Ouchrif M, Ouellette J, Ould-Saada F, Ouraou A, Ouyang Q, Owen M, Owen RE, Ozcan VE, Ozturk N, Pacalt J, Pacey HA, Pachal K, Pacheco Pages A, Padilla Aranda C, Pagan Griso S, Palacino G, Palazzo S, Palestini S, Palka M, Palni P, Panchal DK, Pandini CE, Panduro Vazquez JG, Pani P, Panizzo G, Paolozzi L, Papadatos C, Parajuli S, Paramonov A, Paraskevopoulos C, Paredes Hernandez D, Paredes Saenz SR, Parida B, Park TH, Parker AJ, Parker MA, Parodi F, Parrish EW, Parsons JA, Parzefall U, Pascual Dominguez L, Pascuzzi VR, Pasner JMP, Pasquali F, Pasqualucci E, Passaggio S, Pastore F, Pasuwan P, Pater JR, Pathak A, Patton J, Pauly T, Pearkes J, Pedersen M, Pedraza Diaz L, Pedro R, Peiffer T, Peleganchuk SV, Penc O, Peng C, Peng H, Peralva BS, Perego MM, Pereira Peixoto AP, Pereira Sanchez L, Perepelitsa DV, Perez Codina E, Perini L, Pernegger H, Perrella S, Perrevoort A, Peters K, Peters RFY, Petersen BA, Petersen TC, Petit E, Petousis V, Petridou C, Petroff P, Petrucci F, Pettee M, Pettersson NE, Petukhova K, Peyaud A, Pezoa R, Pezzotti L, Pezzullo G, Pham T, Phillips PW, Phipps MW, Piacquadio G, Pianori E, Picazio A, Piegaia R, Pietreanu D, Pilcher JE, Pilkington AD, Pinamonti M, Pinfold JL, Pitman Donaldson C, Pizzimento L, Pizzini A, Pleier MA, Plesanovs V, Pleskot V, Plotnikova E, Podberezko P, Poettgen R, Poggi R, Poggioli L, Pogrebnyak I, Pohl D, Pokharel I, Polesello G, Poley A, Policicchio A, Polifka R, Polini A, Pollard CS, Polychronakos V, Ponomarenko D, Pontecorvo L, Popa S, Popeneciu GA, Portales L, Portillo Quintero DM, Pospisil S, Postolache P, Potamianos K, Potrap IN, Potter CJ, Potti H, Poulsen T, Poveda J, Powell TD, Pownall G, Pozo Astigarraga ME, Prades Ibanez A, Pralavorio P, Prapa MM, Prell S, Price D, Primavera M, Proffitt ML, Proklova N, Prokofiev K, Prokoshin F, Protopopescu S, Proudfoot J, Przybycien M, Pudzha D, Puri A, Puzo P, Pyatiizbyantseva D, Qian J, Qin Y, Quadt A, Queitsch-Maitland M, Rabanal Bolanos G, Racko M, Ragusa F, Rahal G, Raine JA, Rajagopalan S, Ran K, Rassloff DF, Rauch DM, Rave S, Ravina B, Ravinovich I, Raymond M, Read AL, Readioff NP, Reale M, Rebuzzi DM, Redlinger G, Reeves K, Reikher D, Reiss A, Rej A, Rembser C, Renardi A, Renda M, Rendel MB, Rennie AG, Resconi S, Resseguie ED, Rettie S, Reynolds B, Reynolds E, Rezanova OL, Reznicek P, Ricci E, Richter R, Richter S, Richter-Was E, Ridel M, Rieck P, Rifki O, Rijssenbeek M, Rimoldi A, Rimoldi M, Rinaldi L, Rinn TT, Ripellino G, Riu I, Rivadeneira P, Rivera Vergara JC, Rizatdinova F, Rizvi E, Rizzi C, Robertson SH, Robin M, Robinson D, Robles Gajardo CM, Robles Manzano M, Robson A, Rocchi A, Roda C, Rodriguez Bosca S, Rodriguez Rodriguez A, Rodríguez Vera AM, Roe S, Roggel J, Røhne O, Rojas RA, Roland B, Roland CPA, Roloff J, Romaniouk A, Romano M, Rompotis N, Ronzani M, Roos L, Rosati S, Rosin G, Rosser BJ, Rossi E, Rossi E, Rossi E, Rossi LP, Rossini L, Rosten R, Rotaru M, Rottler B, Rousseau D, Rovelli G, Roy A, Rozanov A, Rozen Y, Ruan X, Ruby AJ, Ruggeri TA, Rühr F, Ruiz-Martinez A, Rummler A, Rurikova Z, Rusakovich NA, Russell HL, Rustige L, Rutherfoord JP, Rüttinger EM, Rybar M, Rye EB, Ryzhov A, Sabater Iglesias JA, Sabatini P, Sabetta L, Sacerdoti S, Sadrozinski HFW, Sadykov R, Safai Tehrani F, Safarzadeh Samani B, Safdari M, Saha P, Saha S, Sahinsoy M, Sahu A, Saimpert M, Saito M, Saito T, Salamani D, Salamanna G, Salnikov A, Salt J, Salvador Salas A, Salvatore D, Salvatore F, Salzburger A, Sammel D, Sampsonidis D, Sampsonidou D, Sánchez J, Sanchez Pineda A, Sandaker H, Sander CO, Sanderswood IG, Sandhoff M, Sandoval C, Sankey DPC, Sannino M, Sano Y, Sansoni A, Santoni C, Santos H, Santpur SN, Santra A, Saoucha KA, Sapronov A, Saraiva JG, Sasaki O, Sato K, Sauerburger F, Sauvan E, Savard P, Sawada R, Sawyer C, Sawyer L, Sayago Galvan I, Sbarra C, Sbrizzi A, Scanlon T, Schaarschmidt J, Schacht P, Schaefer D, Schaefer L, Schäfer U, Schaffer AC, Schaile D, Schamberger RD, Schanet E, Scharf C, Scharmberg N, Schegelsky VA, Scheirich D, Schenck F, Schernau M, Schiavi C, Schildgen LK, Schillaci ZM, Schioppa EJ, Schioppa M, Schleicher KE, Schlenker S, Schmidt-Sommerfeld KR, Schmieden K, Schmitt C, Schmitt S, Schoeffel L, Schoening A, Scholer PG, Schopf E, Schott M, Schouwenberg JFP, Schovancova J, Schramm S, Schroeder F, Schulte A, Schultz-Coulon HC, Schumacher M, Schumm BA, Schune P, Schwartzman A, Schwarz TA, Schwemling P, Schwienhorst R, Sciandra A, Sciolla G, Scuri F, Scutti F, Scyboz LM, Sebastiani CD, Sedlaczek K, Seema P, Seidel SC, Seiden A, Seidlitz BD, Seiss T, Seitz C, Seixas JM, Sekhniaidze G, Sekula SJ, Semprini-Cesari N, Sen S, Serfon C, Serin L, Serkin L, Sessa M, Severini H, Sevova S, Sforza F, Sfyrla A, Shabalina E, Shahinian JD, Shaikh NW, Shaked Renous D, Shan LY, Shapiro M, Sharma A, Sharma AS, Shatalov PB, Shaw K, Shaw SM, Shehade M, Shen Y, Sherwood P, Shi L, Shimmin CO, Shimogama Y, Shimojima M, Shinner JD, Shipsey IPJ, Shirabe S, Shiyakova M, Shlomi J, Shochet MJ, Shojaii J, Shope DR, Shrestha S, Shrif EM, Shroff MJ, Shulga E, Sicho P, Sickles AM, Sideras Haddad E, Sidiropoulou O, Sidoti A, Siegert F, Sijacki D, Silva Oliveira MV, Silverstein SB, Simion S, Simoniello R, Simpson-Allsop CJ, Simsek S, Sinervo P, Sinetckii V, Singh S, Sinha S, Sioli M, Siral I, Sivoklokov SY, Sjölin J, Skaf A, Skorda E, Skubic P, Slawinska M, Sliwa K, Smakhtin V, Smart BH, Smiesko J, Smirnov N, Smirnov SY, Smirnov Y, Smirnova LN, Smirnova O, Smith EA, Smith HA, Smizanska M, Smolek K, Smykiewicz A, Snesarev AA, Snoek HL, Snyder IM, Snyder S, Sobie R, Soffer A, Søgaard A, Sohns F, Solans Sanchez CA, Soldatov EY, Soldevila U, Solodkov AA, Soloshenko A, Solovyanov OV, Solovyev V, Sommer P, Son H, Sonay A, Song WY, Sopczak A, Sopio AL, Sopkova F, Sottocornola S, Soualah R, Soukharev AM, South D, Spagnolo S, Spalla M, Spangenberg M, Spanò F, Sperlich D, Spieker TM, Spigo G, Spina M, Spiteri DP, Spousta M, Stabile A, Stamas BL, Stamen R, Stamenkovic M, Stampekis A, Stanecka E, Stanislaus B, Stanitzki MM, Stankaityte M, Stapf B, Starchenko EA, Stark GH, Stark J, Staroba P, Starovoitov P, Stärz S, Staszewski R, Stavropoulos G, Steinberg P, Steinhebel AL, Stelzer B, Stelzer HJ, Stelzer-Chilton O, Stenzel H, Stevenson TJ, Stewart GA, Stockton MC, Stoicea G, Stolarski M, Stonjek S, Straessner A, Strandberg J, Strandberg S, Strauss M, Strebler T, Strizenec P, Ströhmer R, Strom DM, Stroynowski R, Strubig A, Stucci SA, Stugu B, Stupak J, Styles NA, Su D, Su W, Su X, Suarez NB, Sulin VV, Sullivan MJ, Sultan DMS, Sultansoy S, Sumida T, Sun S, Sun X, Suster CJE, Sutton MR, Svatos M, Swiatlowski M, Swift SP, Swirski T, Sydorenko A, Sykora I, Sykora M, Sykora T, Ta D, Tackmann K, Taenzer J, Taffard A, Tafirout R, Tagiev E, Taibah RHM, Takashima R, Takeda K, Takeshita T, Takeva EP, Takubo Y, Talby M, Talyshev AA, Tam KC, Tamir NM, Tanaka J, Tanaka R, Tapia Araya S, Tapprogge S, Tarek Abouelfadl Mohamed A, Tarem S, Tariq K, Tarna G, Tartarelli GF, Tas P, Tasevsky M, Tassi E, Tateno G, Tayalati Y, Taylor GN, Taylor W, Teagle H, Tee AS, Teixeira De Lima R, Teixeira-Dias P, Ten Kate H, Teoh JJ, Terashi K, Terron J, Terzo S, Testa M, Teuscher RJ, Themistokleous N, Theveneaux-Pelzer T, Thomas DW, Thomas JP, Thompson EA, Thompson PD, Thomson E, Thorpe EJ, Tikhomirov VO, Tikhonov YA, Timoshenko S, Tipton P, Tisserant S, Todome K, Todorova-Nova S, Todt S, Tojo J, Tokár S, Tokushuku K, Tolley E, Tombs R, Tomoto M, Tompkins L, Tornambe P, Torrence E, Torres H, Torró Pastor E, Toscani M, Tosciri C, Toth J, Tovey DR, Traeet A, Treado CJ, Trefzger T, Tresoldi F, Tricoli A, Trigger IM, Trincaz-Duvoid S, Trischuk DA, Trischuk W, Trocmé B, Trofymov A, Troncon C, Trovato F, Truong L, Trzebinski M, Trzupek A, Tsai F, Tsiareshka PV, Tsirigotis A, Tsiskaridze V, Tskhadadze EG, Tsopoulou M, Tsukerman II, Tsulaia V, Tsuno S, Tsybychev D, Tu Y, Tudorache A, Tudorache V, Tuna AN, Turchikhin S, Turgeman D, Turk Cakir I, Turner RJ, Turra R, Tuts PM, Tzamarias S, Tzovara E, Uchida K, Ukegawa F, Unal G, Unal M, Undrus A, Unel G, Ungaro FC, Uno K, Urban J, Urquijo P, Usai G, Uysal Z, Vacek V, Vachon B, Vadla KOH, Vafeiadis T, Vaidya A, Valderanis C, Valdes Santurio E, Valente M, Valentinetti S, Valero A, Valéry L, Vallance RA, Vallier A, Valls Ferrer JA, Van Daalen TR, Van Gemmeren P, Van Stroud S, Van Vulpen I, Vanadia M, Vandelli W, Vandenbroucke M, Vandewall ER, Vannicola D, Vari R, Varnes EW, Varni C, Varol T, Varouchas D, Varvell KE, Vasile ME, Vasquez GA, Vazeille F, Vazquez Furelos D, Vazquez Schroeder T, Veatch J, Vecchio V, Veen MJ, Veloce LM, Veloso F, Veneziano S, Ventura A, Verbytskyi A, Verducci M, Vergis C, Verkerke W, Vermeulen AT, Vermeulen JC, Vernieri C, Verschuuren PJ, Vetterli MC, Viaux Maira N, Vickey T, Vickey Boeriu OE, Viehhauser GHA, Vigani L, Villa M, Villaplana Perez M, Villhauer EM, Vilucchi E, Vincter MG, Virdee GS, Vishwakarma A, Vittori C, Vivarelli I, Vogel M, Vokac P, Von Ahnen J, von Buddenbrock SE, Von Toerne E, Vorobel V, Vorobev K, Vos M, Vossebeld JH, Vozak M, Vranjes N, Vranjes Milosavljevic M, Vrba V, Vreeswijk M, Vu NK, Vuillermet R, Vukotic I, Wada S, Wagner C, Wagner P, Wagner W, Wahdan S, Wahlberg H, Wakasa R, Walbrecht VM, Walder J, Walker R, Walker SD, Walkowiak W, Wallangen V, Wang AM, Wang AZ, Wang C, Wang C, Wang H, Wang J, Wang P, Wang RJ, Wang R, Wang R, Wang SM, Wang S, Wang T, Wang WT, Wang WX, Wang Y, Wang Z, Wanotayaroj C, Warburton A, Ward CP, Ward RJ, Warrack N, Watson AT, Watson MF, Watts G, Waugh BM, Webb AF, Weber C, Weber MS, Weber SA, Weber SM, Wei Y, Weidberg AR, Weingarten J, Weirich M, Weiser C, Wells PS, Wenaus T, Wendland B, Wengler T, Wenig S, Wermes N, Wessels M, Weston TD, Whalen K, Wharton AM, White AS, White A, White MJ, Whiteson D, Whitmore BW, Wiedenmann W, Wiel C, Wielers M, Wieseotte N, Wiglesworth C, Wiik-Fuchs LAM, Wilkens HG, Wilkins LJ, Williams DM, Williams HH, Williams S, Willocq S, Windischhofer PJ, Wingerter-Seez I, Winkels E, Winklmeier F, Winter BT, Wittgen M, Wobisch M, Wolf A, Wölker R, Wollrath J, Wolter MW, Wolters H, Wong VWS, Wongel AF, Woods NL, Worm SD, Wosiek BK, Woźniak KW, Wraight K, Wu SL, Wu X, Wu Y, Wuerzinger J, Wyatt TR, Wynne BM, Xella S, Xiang J, Xiao X, Xie X, Xiotidis I, Xu D, Xu H, Xu H, Xu L, Xu R, Xu T, Xu W, Xu Y, Xu Z, Xu Z, Yabsley B, Yacoob S, Yallup DP, Yamaguchi N, Yamaguchi Y, Yamatani M, Yamauchi H, Yamazaki T, Yamazaki Y, Yan J, Yan Z, Yang HJ, Yang HT, Yang S, Yang T, Yang X, Yang X, Yang Y, Yang Z, Yao WM, Yap YC, Ye H, Ye J, Ye S, Yeletskikh I, Yexley MR, Yin P, Yorita K, Yoshihara K, Young CJS, Young C, Yuan R, Yue X, Zaazoua M, Zabinski B, Zacharis G, Zaffaroni E, Zahreddine J, Zaitsev AM, Zakareishvili T, Zakharchuk N, Zambito S, Zanzi D, Zeißner SV, Zeitnitz C, Zemaityte G, Zeng JC, Zenin O, Ženiš T, Zenz S, Zerradi S, Zerwas D, Zgubič M, Zhang B, Zhang DF, Zhang G, Zhang J, Zhang K, Zhang L, Zhang L, Zhang M, Zhang R, Zhang S, Zhang X, Zhang X, Zhang Y, Zhang Z, Zhao P, Zhao Y, Zhao Z, Zhemchugov A, Zheng Z, Zhong D, Zhou B, Zhou C, Zhou H, Zhou M, Zhou N, Zhou Y, Zhu CG, Zhu C, Zhu HL, Zhu H, Zhu J, Zhu Y, Zhuang X, Zhukov K, Zhulanov V, Zieminska D, Zimine NI, Zimmermann S, Zinonos Z, Ziolkowski M, Živković L, Zoccoli A, Zoch K, Zorbas TG, Zou R, Zwalinski L. Search for Displaced Leptons in sqrt[s]=13 TeV pp Collisions with the ATLAS Detector. PHYSICAL REVIEW LETTERS 2021; 127:051802. [PMID: 34397238 DOI: 10.1103/physrevlett.127.051802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2020] [Revised: 03/03/2021] [Accepted: 06/11/2021] [Indexed: 06/13/2023]
Abstract
A search for charged leptons with large impact parameters using 139 fb^{-1} of sqrt[s]=13 TeV pp collision data from the ATLAS detector at the LHC is presented, addressing a long-standing gap in coverage of possible new physics signatures. Results are consistent with the background prediction. This search provides unique sensitivity to long-lived scalar supersymmetric lepton partners (sleptons). For lifetimes of 0.1 ns, selectron, smuon, and stau masses up to 720, 680, and 340 GeV, respectively, are excluded at 95% confidence level, drastically improving on the previous best limits from LEP.
Collapse
|
237
|
Zhang M, Bromfield EG, Veenendaal T, Klumperman J, Helms JB, Gadella BM. Characterization of different oligomeric forms of CRISP2 in the perinuclear theca versus the fibrous tail structures of boar spermatozoa. Biol Reprod 2021; 105:1160-1170. [PMID: 34309660 DOI: 10.1093/biolre/ioab145] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 04/30/2021] [Accepted: 06/20/2021] [Indexed: 11/13/2022] Open
Abstract
Mammalian sperm carry a variety of highly condensed insoluble protein structures such as the perinuclear theca, the fibrous sheath and the outer dense fibers, which are essential to sperm function. We studied the role of cysteine rich secretory protein 2 (CRISP2); a known inducer of non-pathological protein amyloids, in pig sperm with a variety of techniques. CRISP2, which is synthesized during spermatogenesis, was localized by confocal immunofluorescent imaging in the tail and in the post-acrosomal region of the sperm head. High resolution localization by immunogold labeling electron microscopy (EM) of ultrathin cryosections revealed that CRISP2 was present in the perinuclear theca and neck region of the sperm head, as well as in the outer dense fibers and the fibrous sheath of the sperm tail. Interestingly, we found that under native, non-reducing conditions CRISP2 formed oligomers both in the tail and the head but with different molecular weights and different biochemical properties. The tail oligomers were insensitive to reducing conditions but nearly complete dissociated into monomers under 8 M urea treatment, while the head 250 kDa CRISP2 positive oligomer completely dissociated into CRISP2 monomers under reducing conditions. The head specific dissociation of CRISP2 oligomer is likely a result of the reduction of various sulfhydryl groups in the cysteine rich domain of this protein. The sperm head CRISP2 shared typical solubilization characteristics with other perinuclear theca proteins as was shown with sequential detergent and salt treatments. Thus, CRISP2 is likely to participate in the formation of functional protein complexes in both the sperm tail and sperm head, but with differing oligomeric organization and biochemical properties. Future studies will be devoted to the understand the role of CRISP2 in sperm protein complexes formation and how this contributes to the fertilization processes.
Collapse
|
238
|
Zhang M, Wong SW, Lummus S, Han M, Radmanesh A, Ahmadian SS, Prolo LM, Lai H, Eghbal A, Oztekin O, Cheshier SH, Fisher PG, Ho CY, Vogel H, Vitanza NA, Lober RM, Grant GA, Jaju A, Yeom KW. Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma. AJNR Am J Neuroradiol 2021; 42:1702-1708. [PMID: 34266866 DOI: 10.3174/ajnr.a7200] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2021] [Accepted: 04/05/2021] [Indexed: 01/06/2023]
Abstract
BACKGROUND AND PURPOSE Atypical teratoid/rhabdoid tumors and medulloblastomas have similar imaging and histologic features but distinctly different outcomes. We hypothesized that they could be distinguished by MR imaging-based radiomic phenotypes. MATERIALS AND METHODS We retrospectively assembled T2-weighted and gadolinium-enhanced T1-weighted images of 48 posterior fossa atypical teratoid/rhabdoid tumors and 96 match-paired medulloblastomas from 7 institutions. Using a holdout test set, we measured the performance of 6 candidate classifier models using 6 imaging features derived by sparse regression of 900 T2WI and 900 T1WI Imaging Biomarker Standardization Initiative-based radiomics features. RESULTS From the originally extracted 1800 total Imaging Biomarker Standardization Initiative-based features, sparse regression consistently reduced the feature set to 1 from T1WI and 5 from T2WI. Among classifier models, logistic regression performed with the highest AUC of 0.86, with sensitivity, specificity, accuracy, and F1 scores of 0.80, 0.82, 0.81, and 0.85, respectively. The top 3 important Imaging Biomarker Standardization Initiative features, by decreasing order of relative contribution, included voxel intensity at the 90th percentile, inverse difference moment normalized, and kurtosis-all from T2WI. CONCLUSIONS Six quantitative signatures of image intensity, texture, and morphology distinguish atypical teratoid/rhabdoid tumors from medulloblastomas with high prediction performance across different machine learning strategies. Use of this technique for preoperative diagnosis of atypical teratoid/rhabdoid tumors could significantly inform therapeutic strategies and patient care discussions.
Collapse
|
239
|
Lin J, Ji XJ, Wang AY, Liu JF, Liu P, Zhang M, Qi ZL, Guo DC, Bellomo R, Bagshaw SM, Wald R, Gallagher M, Duan ML. Corrigendum to "Timing of continuous renal replacement therapy in severe acute kidney injury patients with fluid overload: A retrospective cohort study" [J Crit Care. 2021 Aug; 64: 226-236]. J Crit Care 2021; 66:191. [PMID: 34274206 DOI: 10.1016/j.jcrc.2021.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
240
|
Wang LM, Zhang M, Zhou MG, Jiang Y, Li YC, Huang ZJ, Zhao ZP, Zhang X, Li C, Wang LH. [Study on construction and application of technology system of chronic diseases and risk factor surveillance in China]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2021; 42:1154-1159. [PMID: 34814524 DOI: 10.3760/cma.j.cn112338-20210104-00002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
To study and establish a set technology systems of sampling, investigation, quality control, and data analysis of complex sampling for chronic diseases and risk factor surveillance in China based on the requirements of the WHO and China's national conditions, and provide evidence for the policy making and prevention and control evaluation of chronic diseases and technical support for the research of chronic diseases. Through the study of complex sampling technique, adjustment of surveillance points and evaluation of their representatives, a national and provincial representative surveillance system and a complex weighted data analysis were established. According to the relevant plans, actions, and policies in China and other countries, the surveillance content and index system were studied and constructed, which was in line with China's national conditions, "1 + X" steps surveillance, covering the content of questionnaire , physical measurement, and laboratory testing. Based on modern information technology, a three-level platform of information collection and a multi-center laboratory quality control technology system were established, including sampling, information collection, biological sample management, quality control, and result display. Relying on the above research techniques, a national epidemiological investigation was conducted in China, which covered cerebrovascular disease, mental disorders, digestive system disease, and diabetes complications, to obtain the national representative data. This study reflected the innovation of "combination of medicine and prevention" and multi department cooperation in the fields of clinical medicine and public health and provided some big data for the health policy making and the evaluation of the effects of chronic disease prevention and control.
Collapse
|
241
|
Zhang M, Zhu YM, Li YX, Mou YT, Kan H, Fan W, Dai JH, Zheng YJ. [Formation of study population for causal inference]. ZHONGHUA LIU XING BING XUE ZA ZHI = ZHONGHUA LIUXINGBINGXUE ZAZHI 2021; 42:1292-1298. [PMID: 34814546 DOI: 10.3760/cma.j.cn112338-20200612-00839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Epidemiological analysis describes and compares the characteristics of a certain number of people to make causal inferences. The formation of the study population is always the first step. In this paper, we first define the concepts of cross-sections at both individual level and population level and introduce the three assumptions needed in the measurements in observational studies, i. e. the true values of the attributes are stable with time, the attribute variables are independent and the individuals are independent during the measuring process. We also determine that the causal inference research should be unified based on the time of the occurrence or beginning of a postulated cause, or exposure, should be in. Then, based on the dual roles of the population cross-section with causal thinking, we propose that research designs can be classified into two types with different characteristics: history reconstruction research and future exploration research. Finally, we briefly analyze the research design framework and the relationship between estimated effects and different designs. The discussion of the formation of a study population from the perspective of causal thinking can make a foundation for the classification of causal inference research design with appropriate effect parameters, which needs to be further studied.
Collapse
|
242
|
Feng Y, Han M, Qie R, Huang S, Li Q, Guo C, Tian G, Zhao Y, Yang X, Li Y, Wu X, Zhou Q, Zhang Y, Wu Y, Liu D, Hu F, Zhang M, Yang Y, Shi X, Sun L, Hu D. Adherence to antihypertensive medications for secondary prevention of cardiovascular disease events: a dose-response meta-analysis. Public Health 2021; 196:179-185. [PMID: 34246104 DOI: 10.1016/j.puhe.2021.05.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Revised: 05/09/2021] [Accepted: 05/13/2021] [Indexed: 11/25/2022]
Abstract
OBJECTIVES The aim of the study was to explore the association between adherence to antihypertensive medications (AHMs) and the risk of recurrence of cardiovascular disease (CVD) events in patients with a history of CVD events from cohort studies. STUDY DESIGN This is a dose-response meta-analysis. METHODS PubMed and Embase databases were searched up to March 4, 2021, to identify English-language reports of cohort studies that assessed the association of AHM adherence with risk of recurrence of CVD events. Pooled relative risks (RRs) and 95% confidence intervals (CIs) were estimated by using a fixed- or random-effects model. Restricted cubic splines were used to evaluate the possible linear or non-linear association. RESULTS We included nine cohort studies (54,349 patients) in the present meta-analysis. The pooled RR of CVD events was 0.66 (95% CI, 0.54-0.78) for the highest versus lowest AHM adherence category. We did not find any evidence of non-linearity association between AHM adherence and risk of CVD events (Pnon-linearity = 0.534); for patients with a history of CVD events, the risk of CVD events was reduced by 9% for each 20% increase in AHM adherence (RR, 0.91; 95% CI, 0.85-0.97). The results of sensitivity analysis and subgroup analysis were virtually unchanged. CONCLUSIONS The high level of adherence to AHM is an effective strategy for preventing recurrence of CVD events. Patients with a history of CVD events should adhere to AHM.
Collapse
|
243
|
Almeida MN, Zhang M, Lopez WAL, Vilalta C, Sanhueza J, Corzo CA, Zimmerman JJ, Linhares DCL. A comparison of three sampling approaches for detecting PRRSV in suckling piglets. Prev Vet Med 2021; 194:105427. [PMID: 34271476 DOI: 10.1016/j.prevetmed.2021.105427] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2020] [Revised: 06/28/2021] [Accepted: 07/05/2021] [Indexed: 10/20/2022]
Abstract
Determining whether porcine reproductive and respiratory syndrome virus (PRRSV) is circulating within a breeding herd is a longstanding surveillance challenge. Most commonly, piglets in farrowing rooms are sampled to infer the PRRSV status of the sow herd, with sample size based on the expectation of hypergeometric distribution and piglet selection based on simple random sampling (SRS), i.e., randomly selecting individuals from a population in a manner that all individuals have equal chance of being selected. Conceptually straightforward, the assumptions upon which it is based (homogeneous population and independence of individuals) rarely hold in modern swine facilities. Alternative approaches for sample selection include two-stage stratified sampling (2SS), i.e., randomly selecting litters (first stratum) and randomly selecting piglets (second stratum) within selected litters, and risk-based sampling (RBS), i.e., selecting litters with a higher risk of having viremic piglets, and randomly selecting pigs within those litters. The objectives of this study were to 1) characterize the pattern of distribution of PRRSV-viremic piglets in farrowing rooms and 2) compare the efficiency of SRS, 2SS, and RBS for the detection of PRRSV-viremic piglets. In 12 sow farms, serum samples were collected from all 4510 piglets in 422 litters housed in 23 farrowing rooms and tested for PRRSV RNA. At the population level, the distribution of PRRSV-viremic pigs was analyzed for population homogeneity and spatial clustering. At the litter level, litter size and sow parity were evaluated as risk factors. A non-homogeneous distribution of PRRSV-viremic piglets was observed in nearly all farrowing rooms (15/16), and spatial clustering detected on 11 occasions (11/16). Simulated sampling based on farrowing room data determined that 2SS required 1-to-25 fewer samples than SRS to detect ≥ 1 viremic piglet in 13 of 16 rooms and the same number of samples in 3 rooms. RBS required 1-to-7 fewer samples than 2SS to detect ≥ 1 viremic piglet in 7 of 16 rooms, the same number of samples in 6 rooms, and 1 more sample in 3 rooms. Notably, SRS was less efficient than either 2SS or RBS in detecting PRRSV-viremic piglets in farrowing rooms, regardless of the confidence level. It may be concluded that the core assumptions upon which most current surveillance methods are based do not hold in modern farrowing room facilities. Simulation-based sample size tables for SRS and 2SS are provided.
Collapse
|
244
|
Wu M, Sun X, Wang T, Zhang M, Li P. TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells. Clin Transl Oncol 2021; 24:145-153. [PMID: 34216368 DOI: 10.1007/s12094-021-02676-9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2021] [Accepted: 06/22/2021] [Indexed: 12/24/2022]
Abstract
PURPOSE Vascular mimicry (VM) tubules are lumen structures comprised of malignant tumor cells without the participation of endothelial cells. VM simulates blood vessel function in tumors to deliver a sufficient blood supply for proliferation, invasion, and metastasis of malignant tumors, thereby reducing the clinical effects of anti-angiogenic treatments. The elimination or prevention of malignant tumor VM development therefore represents an urgent research goal as a therapeutic strategy to and cut off nutrients required for tumor growth. The GATA transcription factor TRPS1 is abnormally up-regulated in breast cancer, osteosarcoma, prostate cancer, and other tumor tissues, and is instrumental in regulating cell proliferation, differentiation, and tissue growth and development. METHODS Here, we explored the effects of TRPS1 knockdown on VM and the proteins underlying its development in triple-negative breast cancer cell line MDA-MB-231. RESULTS We found that TRPS1 knockdown resulted in obvious inhibition of VM development. Fluorescence microscopy of F-actin and tubulin revealed that loss of TRPS1 function resulted in disruption of cytoskeleton and microtubule formation, respectively. In addition, TRPS1-suppressed cells exhibited reduced accumulation of VM-associated proteins EphA2, MMP-2, MMP-9, VEGF, and VE-cadherin. Moreover, it is interesting to know that the capacity for migration and invasion were limited in MDA-MB-231cells after TRPS1 knockdown and that the average number of VM tubules, their length, and number of intersections were also significantly decreased. CONCLUSIONS Based on our results, and in light of previous studies, we thus proposed that TRPS1 suppression negatively affects vascular mimicry possibly through reduced TRPS1-mediated transcriptional regulation of VM-related protein VEGF-A.
Collapse
|
245
|
Zeng Y, He H, Wang X, Zhang M, An Z. Climate and air pollution exposure are associated with thyroid function parameters: a retrospective cross-sectional study. J Endocrinol Invest 2021; 44:1515-1523. [PMID: 33159683 DOI: 10.1007/s40618-020-01461-9] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2020] [Accepted: 10/26/2020] [Indexed: 02/05/2023]
Abstract
OBJECTIVES There are still controversies about the impact of climatic and environmental factors on thyroid function parameters in healthy populations. We investigated the relationships between climate, air pollution exposure, and thyroid function fluctuations. METHODS We retrospectively reviewed 327,913 individuals attending routine health checks from December 2013 to December 2018. We analyzed the associations between thyroid function and climatic factors using Spearman's correlation analysis. We explored the relationships between thyroid function and air pollution exposure using multiple linear regression analysis, after adjusting for age, sex, season, and outdoor temperature. We also performed subgroup analyses by age and sex and sensitivity analyses of different anti-thyroid peroxidase antibody status. RESULTS Thyroid-stimulating hormone (TSH) and free triiodothyronine (FT3) were negatively associated with outdoor temperature (r = - 0.66, P < 0.001; r = - 0.55, P < 0.001), while free thyroxine (FT4) and FT4/FT3 were positively associated with temperature (r = 0.35, P < 0.001; r = 0.79, P < 0.001). An increase of 10 μg/m3 in fine particulate matter ≤ 2.5 μm (PM2.5) was associated with a decrease of 0.12 pmol/L in FT4 and an increase of 0.07 pmol/L in FT3 (both P < 0.01). FT4/FT3 was significantly negatively associated with PM2.5 (coefficient: - 0.06, P < 0.01). These results remained robust in hierarchical analyses and sensitivity analyses. CONCLUSIONS Thyroid function parameters are associated with climate and air pollution exposure. These factors may influence variations in thyroid function. Our results also highlight the importance of public health interventions to reduce air pollution.
Collapse
|
246
|
Tang T, Zhang M, Wendong L, Hu N, Du X, Ran F. Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-Analysis of Randomized Controlled Trials. J Vasc Surg 2021. [DOI: 10.1016/j.jvs.2021.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
247
|
Zhang M, Wang JY, Li L, Li GM. MiR-506 alleviates myocardial ischemia-reperfusion injury via targeting PI3K/AKT. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2021; 24:12896-12903. [PMID: 33378040 DOI: 10.26355/eurrev_202012_24193] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
OBJECTIVE The aim of this study was to explore the effects of micro ribonucleic acid (miR)-506 and phosphatidylinositol 3-hydroxy kinase (PI3K)/protein kinase B (AKT) pathway on myocardial ischemia-reperfusion injury (MIRI) in rats. MATERIALS AND METHODS A total of 90 healthy rats weighing 260-300 g were selected as research subjects, and divided into three groups, including: Control group (n=30), IR group (n=30), and miRNA treatment group (IR + miR-506 group, n=30). The model was successfully established via threading the coronary artery. The structural differences in myocardial tissues were observed via hematoxylin-eosin (HE) staining in each group. The mRNA expressions of miR-506 and PI3K in myocardial tissues were detected using fluorescence quantitative Polymerase Chain Reaction (qPCR). Meanwhile, AKT protein phosphorylation activity in myocardial tissues was detected as well. The apoptosis of myocardial tissues was detected via terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining. In addition, superoxide dismutase (SOD) activity and malondialdehyde (MDA) content in myocardial tissues were compared in each group. RESULTS In Control group, no structural abnormalities were found in myocardial tissues, and no inflammatory cells were observed. In IR group, myocardial tissues were arranged disorderly, and inflammatory cell infiltration was found. In IR + miR-506 group, myocardial tissue lesions were milder than those in the IR group. qPCR results indicated that the mRNA expressions of miR-506 and PI3K in myocardial tissues were statistically different among groups (p<0.05), with the lowest in the IR group. The expression of miR-506 was evidently higher in IR + miR-506 group than that in the Control group (p<0.05). However, the mRNA expression of PI3K was significantly higher in the Control group than IR + miR-506 group (p<0.05). There was a significant positive correlation between the expressions of miR-506 and PI3K in each group (p<0.05). The phosphorylation activity of AKT protein in IR + miR-506 group was markedly higher than the other two groups (p<0.05). In addition, TUNEL staining demonstrated that the apoptosis rate in Control group, IR group and IR + miR-506 group was only 1.3%, 20.3%, and 9.8%, respectively. SOD activity was remarkably stronger in the Control group (62.7 U/mg pro) than the other two groups (p<0.05). In addition, MDA content was remarkably higher in IR group (0.747 nmol/mg pro) than that in the other two groups (p<0.05). CONCLUSIONS MiR-506 is associated with myocardial injury in rats, which can alleviate myocardial injury through the PI3K/AKT signaling pathway.
Collapse
|
248
|
Zhang M, Bao HL, Wang LM, Zhao ZP, Huang ZJ, Zhang X, Li C, Zhou MG, Wu J, Wang LH. [Analysis of cervical cancer screening and related factors in China]. ZHONGHUA YI XUE ZA ZHI 2021; 101:1869-1874. [PMID: 34192843 DOI: 10.3760/cma.j.cn112137-20210108-00054] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Objective: To study the cervical cancer screening rate and related factors among women in China. Methods: In 2015, Chinese Chronic Diseases and Risk Factors Surveillance in Adults was conducted in 298 counties or districts using the multistage stratified cluster sampling in China. The study investigated 91 348 women aged 20 years or older who lived in the local at least 6 months in the past year. We collected the information about cervical cancer screening and socio-demographic factors through face-to-face interview. The screening rate was calculated by the complex sampling design and populating weighting. Rao-Scott χ2 was used to test the differences in screening rates within subgroups. Multivariable logistic regression was used to explore the factors associated with the uptake of cervical cancer screening. Results: The mean age of participants was (51±14) years old. The cervical cancer screening rate was 23.6% (n=21 346), and there was a significant difference in the screening rates among age groups. The cervical cancer screening rate in women aged 40-49 years was 34.8% (n=7 043). There was significant difference in the screening rates among geographic areas and the highest screening rate was 27.9% (n=6 707) in the eastern China. The more likelihood of uptake of cervical cancer screening was significantly associated with living in high-income regions, higher education, non-agriculture employment, higher household income, having medical insurance, and having health check-up during the past three years, and the cervical screening rate was higher (all P<0.05) . Conclusion: The cervical cancer screening rate is low in China and there was significant difference in the age and geographic areas. The uptake of cervical cancer screening is associated with local economic status, household income, education, employment, health insurance, and health check-up.
Collapse
|
249
|
Zhang M, Fu RX, Ge RJ, Sun CZ, Nan FF. FRACTIONATED TOTAL‐BODY IRRADIATION AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS STEM‐CELL SUPPORT IN PATIENTS WITH T‐CELL LYMPHOBLASTIC LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.37_2881] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
250
|
Zhang M, Xu P, Wang L, Cheng S, Zhao W. GENETIC SUBTYPE GUIDED RITUXIMAB‐BASED IMMUNOCHEMOTHERAPY IMPROVES OUTCOME IN NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: FIRST REPORT OF A RANDOMIZED PHASE 2 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.26_2879] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|